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1. INTRODUCTION 
1.1. Male reproductive system 
 
In mammals the male reproductive system is composed of several different organs, 
namely the gonads (testis), epididymis, ductus deferens, prostate, and the penis (Meniru, 
2001). Spermatozoa produced in the testes are transported to the epididymis through the 
rete testis and the efferent ducts, where they mature and acquire their capacity for 
motility to reach and fertilize the oocyte. The sperm maturation is also influenced during 
ejaculation by the secretions of the accessory sex glands (seminal vesicles, prostate and 
bulbourethral glands) (Knorr et al., 1970). 
 
1.2. Structure and function of the testis  
  
The testes development from the sex cord is regulated by the sex-determining region of 
Y-chromosome gene (SRY) (Koopman, 1995). SRY and its downstream target SRY-box 
9 (Sox9) induce the differentiation of somatic cell precursors to Sertoli cells, a critical 
step in testis morphogenesis (Morais da Silva et al., 1996). The mammalian testis is 
constituted of two compartments: the seminiferous tubules and the interstitial space, 
which are separated by the basal lamina produced by the peritubular and Sertoli cells 
(Elftman, 1963; Fijak and Meinhardt, 2006; Li et al., 2012; Zhao et al., 2014). The two 
primary functions of the testis are the formation of sperms (spermatogenesis) taking 
place in the seminiferous epithelium and the production and secretion of the male steroid 
hormones (steroidogenesis) mainly synthesized by the Leydig cells in the interstitial 
space (Figure 1) (Zhao et al., 2014).  
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Figure 1. Scheme illustrating the structure of the testis. The mammalian testis is 
constituted of two compartments: the seminiferous tubules (ST) and the interstitial space 
(interstitium), which are separated by the basal lamina (BL) produced by the Sertoli and 
peritubular cells (PTC). In the seminiferous tubules, different stages of developing germ 
cells (spermatogonia (Spg), primary spermatocytes (PSC), secondary spermatocytes 
(SSC), round spermatids (RS), and elongated spermatids (ES)) are intimately associated 
with Sertoli cells. The tight junctions between neighboring Sertoli cells form the blood-
testis barrier (BTB), which separates spermatogonia from most spermatocytes and all 
spermatids. Leydig cells (LC) are the major population of cells in the interstitial space. 
The interstitial space also contains various types of immune cells such as testicular 
macrophages (MФ), dendritic cells (DC), few mast cells (MC), and blood vessels (BV). 
(Zhao et al., 2014; with the permission of the publisher, license number: 
4303600412665). 
 
During spermatogenesis, spermatogonia undergo mitosis and form primary 
spermatocytes (Figure 1) (Zhao et al., 2014). The primary spermatocyte enter meiosis 
and divide into two secondary spermatocytes (Meiosis I) (Bustos-Obregon et al., 1975). 
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Then each secondary spermatocyte divides into two haploid spermatids (Meiosis II), 
which transform into spermatozoa (Bustos-Obregon et al., 1975). The later process, 
called spermiogenesis, is characterized by the removal of spermatid cytoplasm, 
formation of the acrosome, condensation of DNA in the sperm head, and tail 
establishment (Bustos-Obregon et al., 1975). Except germ cells, the seminiferous 
tubules also contain Sertoli cells surrounded by one (e.g. rats and mice) or more (e.g. 
humans) layers of peritubular cells (Maekawa et al., 1996; Yang et al., 2015). The 
Sertoli cells extend from the basal membrane to the lumen of the tubules and support the 
development of the different stages of germ cells (Figure 1) by providing essential 
nutrients and growth factors (Griswold, 1995; Fijak and Meinhardt, 2006). Sertoli cells 
also play a key role in the regulation of spermatogenesis and maintenance of testicular 
immune privilege primarily by secreting anti-inflammatory factors (e.g. galectin-1 (Gal-
1), transforming growth factor β1 (TGFβ1) and indoleamine 2, 3-dioxygenase (IDO)) in 
addition to forming the BTB (Fijak and Meinhardt, 2006; Zhao et al., 2014; França et 
al., 2016; Gao et al., 2016). Peritubular cells possess properties of smooth muscle like 
cells and surround the seminiferous tubules. They are responsible for tubular 
contractility and the transportation of immotile spermatozoa to the epididymis. 
Moreover, they are involved in the maintenance of the spermatogonial stem cell niche by 
secreting glial cell line-derived neurotrophic factor (GDNF) (Albrecht, 2009; 
Mayerhofer, 2013; Chen et al., 2014). 
 
In the interstitial space of the testis reside the Leydig cells and immune cells such as 
macrophages, dendritic cells, and mast cells (Figure 1) (Zhao et al., 2014). In the Leydig 
cells steroidogenesis takes place, a process that is converting cholesterol to biologically 
active steroid hormones involving mitochondria and the smooth endoplasmic reticulum 
(Tremblay, 2015). In the testis, testosterone is the most important steroid hormone, 
which plays an important role in the formation of the male phenotype, sexual behavior 
and maintenance of spermatogenesis (Wilson, 1999). Steroidogenesis in Leydig cells is 
largely regulated by luteinizing hormone (LH) through affecting expression of 
steroidogenic acute regulatory protein (StAR) (Haider, 2007). 
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1.3. Immune privilege of the testis  
 
The testis is an immune privileged organ as defined by the capacity to tolerate not only 
new testicular autoantigens but also allo- and xenografts experimentally transplanted 
into the testis environment. After the establishment of the immune system during 
puberty male germ cells enter meiosis and transform into specialized spermatozoa. 
During this process, a myriad of new autoantigens is produced, which has to be tolerated 
by the immune system (Fijak and Meinhardt, 2006). The immune privileged status of the 
testis has also been appreciated by studies showing that allo- and xenografts transplanted 
into the interstitial space of the rat testis could survive long term (Head et al., 1983; 
Setchell, 1990). The tissues transplanted include skin, pancreatic islets, and parathyroid 
fragments (Ferguson and Scothorne, 1977; Whitmore and Gittes, 1977; Head et al., 
1983; Mital et al., 2010). More interestingly, the transplantation of spermatogonia into 
the seminiferous tubules of infertile recipient mice could reestablish spermatogenesis 
and produce mature spermatozoa, even across species barriers in some cases (Brinster 
and Zimmermann, 1994; Dobrinski, 2008). These studies illustrate that the environment 
of the testis could protect allo- and xenografts from immune attack and define the testis 
as an immune privileged site. Therefore, several mechanisms that include the BTB, 
somatic and immune cells and hormones (testosterone) are involved in the maintenance 
of the testicular immune privilege (Figure 2) (Zhao et al., 2014). 
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Figure 2. Schematic of the BTB, somatic and immune cells and molecules that 
support immune privilege in the testis. Sertoli and Leydig cells secrete multiple 
immunosuppressive factors (activin A, Gal-1, PDL-1, TGF-β, ProS and testosterone) 
which suppress of immune cell activation. Macrophages exhibit immunosuppressive 
properties by producing anti-inflammatory cytokines such as IL-10 and TGF-β. Gas6, 
growth arrest-specific gene 6; LC, Leydig cell; MC, mast cell; Mϕ, testicular 
macrophages; PDL-1, programmed death ligand-1. (Zhao et al., 2014; with the 
permission of the publisher, license number: 4350711055905). 
 
1.3.1. Blood – testis barrier 
 
The BTB is the physical separation of newly developing germ cells from the immune 
system. It is established by tight junctions between Sertoli cells (Figure 2) (Zhao et al., 
                                                                                                                INTRODUCTION 
  - 14 -  
 
2014). The BTB is made up of various integral membrane proteins including junctional 
adhesion molecules, claudin 1 and claudin 11. It divides the seminiferous epithelium into 
two different compartments: (a) the basal compartment containing the spermatogonia, 
pre-leptotene, and leptotene spermatocytes and (b) the abluminal compartment carrying 
zygotene, pachytene and secondary spermatocytes, haploid spermatids, and spermatozoa 
(Mital et al., 2011). This barrier can limit the access of immune cells to autoantigens 
expressed in meiotic and haploid germ cells (Mital et al., 2011). During infection, 
inflammation, and trauma, the integrity of the BTB is impaired, which is often 
association with germ cell loss (Dulin et al., 2011; Meinhardt and Hedger, 2011). In the 
rete testis there is no BTB, so spermatozoa and immune cells could get into contact. This 
latter factor highlights the view that a physical barrier is not sufficient and for protective 
function further means by the testicular somatic and immune cells as well as hormones 
(testosterone) are needed to provide an immune privileged environment in the testis. 
 
1.3.2. Role of somatic cells in the maintenance of testicular immune 
privilege 
 
Most evidence for a role of Sertoli cells in immunosuppression is based on co-
transplantation studies showing that Sertoli cells co-transplanted with pheochromocytes 
(neuroendocrine cells)  or liver cells were creating an immune privileged environment 
(Mital et al., 2010). In an autoimmune type 1 diabetes model, syngeneic pancreatic islets 
are rejected by autoimmune T cells and autoantibodies, while co-transplantation of 
Sertoli cells with allogeneic pancreatic islets can significantly prolong their survival 
(Suarez-Pinzon et al., 2000). Gao et al. reported that Sertoli cells could secrete Gal-1, 
which is able to promote differentiation of tolerogenic dendritic cells and regulatory T 
cells (Treg cells) (Gao et al., 2016). More recently, Tung et al. found that non-
sequestered meiotic germ cell antigens are phagocytosed in the apical part of Sertoli 
cells and egress basally through intracellular transport which triggers a Treg cell-
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dependent systemic tolerance (Tung et al., 2017). Under stress conditions such as 
infection or inflammation, Sertoli cells can express IL-6, tumor necrosis factor alpha 
(TNFα), IL-1β, and Fas ligand, which are involved in the disruption of spermatogenesis 
and induction of germ cell apoptosis (O’Bryan and Hedger, 2008). Peritubular cells are 
also suggested to play a role in the maintenance of the testicular immune privilege 
(Schuppe and Meinhardt, 2005). Peritubular cells produce TGFβ, a cytokine which 
displays immunosuppressive and anti-inflammatory activities (Skinner and Moses, 
1989). Under inflammatory conditions, they also express immune mediators, such as IL-
6, cyclooxygenases-2 (COX-2), activin A and Toll-like receptors (de Winter et al., 1994; 
Schell et al., 2008; Mayerhofer, 2013; Mayer et al., 2016). Nonetheless, the role of 
Sertoli and peritubular cells in the maintenance of immune privilege or inflammatory 
responses in the testis remains to be further elucidated. 
 
1.3.3. Involvement of testicular immune cells in the formation of 
immune privilege 
 
Testicular immune cells including testicular macrophages, dendritic cells, and T cells, all 
located in the interstitial space, are also involved in the maintenance of testicular 
immune privilege through several mechanisms (e.g. suppression of antigen-specific 
immunity and T cell activation, macrophage polarization).  
 
1.3.3.1. Testicular macrophages and dendritic cells 
 
Testicular macrophages are majorly involved in the regulation of spermatogenesis and 
steroidogenesis, the immune response to inflammation and infection, and the 
maintenance of testicular immune privilege. Testicular macrophages are residing in the 
interstitial space and comprising the largest population of immune cells (about 20–25% 
of the interstitial cells) in rodents (Niemi et al., 1986; Itoh et al., 1995). The majority 
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(~80%) of testicular macrophages possess an anti-inflammatory/immunoregulatory M2 
phenotype, as defined by the expression of the scavenger receptor CD163 as well as the 
production of the anti-inflammatory cytokine IL-10 (Wang et al., 2017).  
 
Under normal or inflammatory conditions testicular macrophages express relatively low 
levels of pro-inflammatory cytokines (TNFα and IL-6) compared to macrophages from 
other organs, a means accompanied by the high expression of anti-inflammatory factors 
(IL-10) (Bhushan et al., 2015). Mechanistically, expression of TLR pathway-specific 
genes such as CD14 and MyD88 associated with TNFα and IL-6 production is also 
relatively low in testicular macrophages (Bhushan et al., 2015). However, testicular 
macrophages still preserve some capacity for innate immune responses by the activation 
of AP-1 and MAP kinase signaling pathways after LPS stimulation (Bhushan et al., 
2015). These contradictory features enable testicular macrophages to maintain the 
immune privilege of the testis under normal conditions, while protecting testicular cells 
from pathogens by the balanced pro-inflammatory activity. Moreover, testicular 
macrophages express several molecules involved in spermatogonial proliferation and 
differentiation, such as colony stimulating factor 1 (CSF1) and enzymes required for 
retinoic acid (RA) biosynthesis. In agreement, the transient depletion of macrophages in 
the adult mouse testis results in a reduction of spermatogonial numbers (DeFalco et al., 
2015). Under pathological conditions such as infection and/or sterile inflammation 
(orchitis), the number of M1 macrophages dramatically increases and disrupts the 
balance of M1/M2 macrophages. This is thought to a disturbance of the testicular 
immune privilege, impairment of the BTB and sloughing of germ cells, causing 
infertility (Rival et al., 2008; Theas et al., 2008; Fijak et al., 2018).  
 
Dendritic cells as professional antigen presenting cells are also present in the rodent 
testis under physiological conditions (Wang and Duan, 2016). Their maturation state is 
regarded as a key point in the induction of peripheral immune tolerance or contrary in 
the development of autoimmunity. Under normal conditions, testicular dendritic cells are 
immature and functionally tolerogenic characterized by the differential expression of 
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antigen presenting molecules (major histocompatibility complex class II (MHC class 
II)), co-stimulatory molecules (CD80, CD86), chemokine receptors (CCR2, CCR7) and 
cytokines (IL-10, IL-12, TNFα) (Rival et al., 2007). 
 
1.3.3.2. T cells 
 
Besides testicular macrophages and dendritic cells, T cells are also involved in the 
maintenance of immune privilege in the testis. T cells such as suppressor CD8+ cells, 
NK T cells and Treg cells are rarely found in the rat, mouse and human testis (Mukasa et 
al., 1995; Tompkins et al., 1998; Schuppe et al., 2008; Jacobo et al., 2009; Duan et al., 
2011). Their function involves the modulation of immune responses by increasing 
cellular immune surveillance and inhibiting antigen specific T cell responses in the adult 
testis (Hedger, 1997; Li et al., 2012). Specifically, the population of immunoregulatory 
T cells such as CD4+CD25+Foxp3+ T cells and CD8+Foxp3+ T cells are thought to 
suppress antigen specific T cell responses in the adult rodent testis (Fijak et al., 2011b, 
2015; Jacobo et al., 2015; Tung et al., 2017). 
 
1.3.4. Testosterone has immunosuppressive functions in testicular 
immune privilege 
 
An increasing body of evidence indicates immunosuppressive features for testosterone. 
Evidence derived from clinical and epidemiological studies revealed that women are 
more susceptible to autoimmune diseases compared to men, to which the 
immunosuppressive properties of androgens are thought to contribute (Cutolo et al., 
2004). Testosterone supplementation exerts an immunomodulatory and protective effect 
during development of experimental autoimmune diseases such as experimental 
autoimmune orchitis and adjuvant-induced arthritis (Harbuz et al., 1995; Fijak et al., 
2011b). In this regard, testosterone can polarize blood monocytes towards M2 phenotype 
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macrophages mediated by elevated expression and autocrine action possibly of the anti-
inflammatory cytokine IL-10 (Wang et al., 2017). Moreover, testosterone can also 
promote the differentiation of rat splenic T cells towards Treg cells with 
immunosuppressive features (Fijak et al., 2015). These data indicate that androgens play 
an important role in maintaining the balance between autoimmune responses and 
tolerance. A link between androgens and testicular immune privilege was further 
strengthened in experiments using conditional knockout of androgen receptors in Sertoli 
cells. Interestingly, specific deletion of the androgen receptor in Sertoli cells 
compromises testicular immune privilege, likely caused by disruption of the BTB (Meng 
et al., 2011). In line with these data, previous studies suggested that androgens can 
regulate the permeability of the BTB by its effects on the kinetics of endocytosis and the 
recycling of integral membrane proteins such as occludin, JAM-A, and N-cadherin in 
Sertoli cells (Meng et al., 2005; Yan et al., 2008). Testicular fluid, which contains almost 
10 times higher concentrations of testosterone than serum, displays the 
immunosuppressive properties, an effect partly abolished by using the anti-androgen 
flutamide (Wang et al., 2017). In addition, administration of testosterone prior to 
stimulation with LPS significantly decreases the expression of TNFα in isolated Sertoli 
or peritubular cells (Fijak et al., 2015). Taken together, there are clear indications that 
androgens have a critical function in maintaining testicular immune privilege. 
 
1.4. Galectins 
 
In all organisms, galectins are amongst the most broadly expressed types of lectins. A 
typical characteristic is a shared carbohydrate-recognition domain (CRD), which binds 
to β-galactose-containing glycoconjugates (Cummings and Liu, 2017). Galectins have a 
variety of biological functions, that include the regulation of immune cell activity, 
induction of effector T cell apoptosis, pathogen recognition, and promotion of tumor cell 
metastasis (Cummings and Liu, 2017).  
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Galectins are widely expressed in mammals and divergent galectins can be found in a 
single species (up to 15 in rodent) (Cummings and Liu, 2017). A list of galectins in 
vertebrate is shown in Figure 3a (Cummings and Liu, 2017). The shared galectin CRD 
has approximately 130 amino acids, although only eight residues, which have been 
shown to be related to glycan binding, are almost invariant (Barondes et al., 1994). Part 
of the conserved sequence motif in galectins is shown in Figure 3b, along with a 
comparison between several human galectins.  
 
According to the number and organization of their CRD, galectins have been divided 
into three major groups (Figure 3a), including (a) prototypical galectins (galectin-1, -2, -
7, -10, -11, -13, -14, and -15) that contain one CRD. This could form monomers, dimers 
and oligomers in a concentration-dependent manner. (b) Chimera-type galectins 
(galectin-3), which have one C-terminal CRD connected with N-terminal conserved 
amino acids through which it could form oligomers, and (c) tandem-repeat galectins 
(galectin-4, -6, -8, -9, and -12, which consist of two CRDs connected by a peptide linker 
(Barondes et al., 1994; Rabinovich and Toscano, 2009; Liu and Rabinovich, 2010). 
Some galectins display species specific characteristics, for example galectin-5 
(prototype) and galectin-6 (tandem repeat) that are expressed in rodents, but not in 
humans. Galectin-11 (prototype) has only been found in sheep (Cummings and Liu, 
2017). 
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Figure 3. Different types of galectins, their organization and conserved amino acid 
sequences. (a) Fifteen different vertebrate galectins are classified into three groups: 
prototypical galectins, chimera-type galectins and tandem repeat galectins. (b) Examples 
of conserved amino acid sequences of some human galectins are shown. (Cummings and 
Liu, 2017; with the permission of the publisher, and copyright at the Consortium of 
Glycobiology Editors, La Jolla, California, published by Cold Spring Harbor Laboratory 
Press). 
 
Galectins are synthesized on cytosolic ribosomes without a signal peptide, which results 
in the secretion of galectins through an endoplasmic reticulum- and Golgi- independent 
pathway (Nickel, 2005). However, the details of the secreting pathway of galectins are 
still elusive. Besides vertebrates, galectins are also widely found in fungi and 
invertebrates (Vasta, 2012).  
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1.4.1. Galectin-1 (Gal-1) 
 
Gal-1 (a ~14 kDa protein) is the first described member of the galectin family. It is 
defined as an S-type lectin due to the abundance of cysteine residues (Cedeno-Laurent 
and Dimitroff, 2012; Cummings and Liu, 2017). Gal-1 is widely expressed in tissues of 
many vertebrates and invertebrates and requires reducing conditions to maintain its 
activity and stability (Cedeno-Laurent and Dimitroff, 2012; Cummings and Liu, 2017). 
Through binding to specific glycan structures, Gal-1 is involved in a variety of 
physiologic and pathologic processes including mRNA splicing, pathogen recognition, 
selective induction of Th1 and Th17 apoptosis, inhibition of T cell trafficking, expansion 
of tolerogenic dendritic cells and Treg cells, maintenance of the maternal-fetal tolerance, 
induction of pro-angiogenesis in anti-VEGF refractory tumors and suppression of 
autoimmune pathology (Toscano et al., 2006, 2007; Norling et al., 2008; Ilarregui et al., 
2009; Rabinovich and Croci, 2012; Croci et al., 2014). Moreover, Gal-1 plays a role as a 
master regulator of clinically relevant inflammatory response gene expression in 
osteoarthritic chondrocytes by stimulating NFκB-mediated inflammation (Osório, 2016). 
 
The structure of Gal-1 consists of two anti-parallel β-sheets with conserved amino acid 
residues in the CRD, which is also observed in other galectins (Figure 4a) (López-
Lucendo et al., 2004; Cedeno-Laurent and Dimitroff, 2012). Through van der Waals' 
force and hydrogen bond formation, the CRD of Gal-1 can recognize and bind 
lactosamine (LacNAc) (Figure 4b) (López-Lucendo et al., 2004). Gal-1 affinity to 
LacNAc is largely mediated by defined key amino acids (His45, Asn47, Arg49, Val60, 
Asn62, Trp69, Glu72, and Arg74) (Cedeno-Laurent and Dimitroff, 2012). Gal-1 can bind 
to only the LacNAc sequence positioned on complex O-glycans and N-glycans linked 
glycoproteins or glycolipids, but not to soluble LacNAc disaccharides. The multivalent 
binding of Gal-1 results in high-affinity binding, because the affinity of each CRD to 
each glycan ligand is synergistic and additive (Thiemann and Baum, 2016). 
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Figure 4. Ribbon diagram of the homodimeric structure and architecture of Gal-1 -  
ligand binding. (a) Two anti-parallel β-sheets (pink and green) fold into a binding 
pocket, the CRD, which binds to lactose (red). (b) Structure of lactosamine (LacNAc), 
consisting of galactose (yellow) and N-acetylglucosamine (blue). (Thiemann and Baum, 
2016; with the permission of the publisher, license number: 4280080787751).  
 
The function of Gal-1 is predominantly affected by its cellular location. Intracellular 
Gal-1 is mostly monomeric, and mediates cell growth, migration, and invasion through 
protein - protein interactions with cytoplasmic Harvey rat sarcoma viral oncogene 
homolog (H-Ras) (Paz et al., 2001; Zhang et al., 2014). Secreted Gal-1 spontaneously 
dimerizes and concentrates at the cell surface, which in turn binds to glycoconjugates 
located at the cellular surface and forms galectin - glycan complexes that influence 
intracellular signaling pathways and further regulates cell processes such as apoptosis, 
angiogenesis, migration and proliferation (Cedeno-Laurent and Dimitroff, 2012; Elola et 
al., 2015).  
 
The synthesis of complex glycans serving as Gal-1 binding molecules on cell 
membranes depends on the synchronized activities of glycan-modifying enzymes such 
as glycosyltransferases and glycosidases (Figure 5) (Cedeno-Laurent and Dimitroff, 
2012). More specifically, expression of core 2 glucosaminyl (N-acetyl) transferase 1 
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(Gcnt1) for the synthesis of the backbone of Gal-1 ligands (core 2 O-glycans), promotes 
binding of Gal-1 to the cell surface (Cabrera et al., 2006). Similarly, mannosyl (α-1,3-)-
glycoprotein ß-1,2-N-acetylglucosaminyltransferases (Mgat) like Mgat5, which initiates 
the formation of the polylactosamine branch on N-glycans, also increase Gal-1 binding 
(Demetriou et al., 2001). On the contrary, expression of ST6 beta-galactoside α-2-6-
sialyltransferase 1 (St6gal1), which can add a terminal sialic acid to the galactose 
residue via an α-2-6-linkage on an N-glycan branch, abrogates Gal-1 binding to some 
terminal N-acetylglucosamines (Toscano et al., 2007). In cultured T cells, 
overexpression of St6Gal1 prevents Gal-1 binding and thus cell death (Amano et al., 
2003). 
 
 
Figure 5. The function and influence of glycosyltransferases on Gal-1 binding to 
glycan ligands. There are three important post-translational mechanisms that influence 
the affinity of Gal-1 binding to glycan ligands: (a) activity of the core 2 glucosaminyl 
(N-acetyl) transferase 1 (Gcnt1) for the synthesis of core 2 O-glycans, which built the 
backbone of Gal-1 ligands, (b) branching of N-glycans by mannosyl (α-1,3-)-
glycoprotein ß-1,2-N-acetylglucosaminyltransferases 5 (Mgat5, promotes Gal-1 
binding), and (c) suppression of ST6 beta-galactoside α-2-6-sialyltransferase 1 (St6gal1) 
activity, that abrogates Gal-1 binding to some terminal N-acetylglucosamines by adding 
α-2-6-sialic acid. (Thiemann and Baum, 2016; with the permission of the publisher, 
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license number: 4280080787751). 
 
1.4.2. Gal-1 in autoimmune diseases and the testis 
 
By binding to specific cell surface glycan structures, Gal-1 acts as a homeostatic 
immune inhibiting factor, which is involved in the selective induction of Th1 and Th17 
apoptosis (Toscano et al., 2007), inhibition of T cell trafficking (Norling et al., 2008), 
expansion of tolerogenic dendritic cells and regulatory T cells (Toscano et al., 2006; 
Ilarregui et al., 2009), decreased activation of M1 microglia (Starossom et al., 2012), 
maintenance of maternal-fetal tolerance (Blois et al., 2007), induction of pro-
angiogenesis in anti-VEGF refractory tumors (Croci et al., 2014) and suppression of 
autoimmune pathologies (Rabinovich and Croci, 2012).  
 
Consequently, administration of Gal-1 reduces the severity and delays the onset in 
experimental in vivo models of chronic autoimmune diseases such as autoimmune 
diabetes, autoimmune retinal disease, experimental autoimmune encephalomyelitis, 
experimental autoimmune uveitis, collagen-induced arthritis, and experimental 
autoimmune orchitis (Rabinovich et al., 1999; Toscano et al., 2006; Perone et al., 2009; 
Rabinovich and Toscano, 2009; Starossom et al., 2012; Pérez et al., 2015). In a 
glycosylation-dependent manner Gal-1 ameliorates inflammation in autoimmune 
disorders (Méndez-Huergo et al., 2017).  
 
At the same time, targeted deletion of Gal-1 significantly increases the severity of 
inflammation in mouse models of collagen-induced arthritis and experimental 
autoimmune encephalomyelitis (Starossom et al., 2012; Iqbal et al., 2013). On the 
contrary, mice lacking Gal-1 develop a reduced incidence and severity of symptoms in 
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experimental autoimmune orchitis (Pérez et al., 2015), which indicates different 
functions for Gal-1 in the testis. 
 
Interestingly, Gal-1 expression in the testis exhibits a stage-specific pattern during the 
spermatogenic cycle. Immunostaining of Gal-1 in Sertoli cells is found mainly at stages 
X–II and on apical stalks during spermiation (Dettin et al., 2003). Gal-1 is located in 
cytoplasmic projections and nuclei of Sertoli cells as well as on heads and tails of late 
spermatids (Dettin et al., 2003). Moreover, an in vitro study showed administration of 
recombinant Gal-1 can induce rat Leydig cell apoptosis and thus reduces testosterone 
production in a dose-dependent fashion (Martinez et al., 2004). Interestingly, Gal-1 
regulates the sperm fertilizing capacity both in vitro and in vivo. Mechanistically, Gal-1-
deficient sperm display defects in hyperactivation and progesterone-induced acrosome 
reaction, features that could be rescued by exposure of the sperms to recombinant Gal-1 
(Vasen et al., 2015). Furthermore, Gal-1 is also expressed in human Sertoli cells 
(Wollina et al., 1999; Chui et al., 2011), but whether this affects the immunoregulatory 
functions of Sertoli cell has not been elucidated yet. 
 
1.5. Male infertility 
1.5.1. Epidemiology and etiology of male infertility 
 
As defined by the World Health Organization (WHO): “Infertility is the inability of a 
sexually active, non-contracepting couple to achieve pregnancy in one year” (Rowe et 
al., 2000). Approximately 50% of infertility cases are due to male factors (Rowe et al., 
2000). Male infertility could result from physical issues, infections, genetic reasons as 
well as environmental factors (Jungwirth et al, 2017). However, 30–45% of these 
deficiencies are still idiopathic. The etiology of male infertility can also be categorized 
in pre-testicular, testicular and post-testicular reasons (Henkel and Schill, 2003; 
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Gudeloglu and Parekattil, 2013; Kumar and Singh, 2015). Pre-testicular factors of male 
infertility are mainly related by endocrine disorders characterized by dysregulated sex 
steroid secretion (e.g. Kallmann syndrome, hypothalamic or pituitary disorders) 
(Gudeloglu and Parekattil, 2013). Testicular factors of infertility are categorized as 
congenital, acquired or idiopathic disorders that result in spermatogenic failure 
(Gudeloglu and Parekattil, 2013). Congenital testicular causes include testicular 
dysgenesis (cryptorchidism), genetic disorders (Klinefelter's syndrome: 47, XXY, or 
XXY syndrome, Y chromosome deletions), and spermatogenic arrest (maturation 
abnormalities). Acquired testicular factors consist of trauma, viral diseases (mumps), 
bacterial infections (E. coli, Chlamydia, Enterobacter spp, Gonorrhea), varicocele, or 
sterile autoimmune inflammation of the testes. Post-testicular factors consist of 
obstructions or ejaculatory disorders, which both affect the transport of spermatozoa 
(Henkel and Schill, 2003).  
 
1.5.2. Male infertility associated with inflammation  
 
Infection and inflammation of the male genital tract are considered as one of the most 
important identifiable etiologies of male infertility (Weidner et al., 2013). Testicular 
inflammation (orchitis) is characterized by the presence of inflammatory infiltrates in 
the testicular interstitium and associated disruption of seminiferous tubules, that can lead 
to partial or total impairment of spermatogenesis (Schuppe and Meinhardt, 2005; Haidl 
et al., 2008). Acute epididymitis, orchitis or combined epidididymo-orchitis caused by 
infection show clinical symptoms that can often be successfully treated with antibiotics 
and/or antiphlogistics. Post- or non-infectious chronic orchitis is hazardous because it is 
not associated with discomfort or pain (Fijak and Meinhardt, 2006; Schuppe et al., 2008, 
2017; Jungwirth et al., 2012, 2018; Pilatz et al., 2015; Fijak et al., 2018). However, in a 
noninfectious environment inflammatory reactions in the testis can also be triggered by 
physical trauma or chemical noxae, which could induce germ cell apoptosis, increased 
production of pro-inflammatory cytokines as well as immune cell infiltration (Schuppe 
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et al., 2008). In the majority of patients, sub-acute or chronic inflammatory reactions in 
the testis remain asymptomatic until advanced stages of the disease. At the same time, 
no specific seminal or serum markers are available for diagnosis of chronic testicular 
inflammation. As the diagnosis of chronic orchitis is difficult, it is assumed that many 
cases are neglected in the clinic as an underlying reason of male infertility (Schuppe et 
al., 2008; Pilatz et al., 2015). 
 
1.5.3. Experimental autoimmune orchitis 
 
EAO is a rodent model to study organ-specific autoimmunity and chronic testicular 
inflammation that reproduces pathological changes also seen in some cases of human 
immunological infertility (Tung and Teuscher, 1995; Lustig et al., 2013; Aslani et al., 
2015; Fijak et al., 2018). The EAO model in rodents is usually induced by immunization 
with homologous testicular protein extracts in incomplete or complete Freund’s 
adjuvant, followed by administration of inactivated Bordetella pertussis bacteria or 
Bordetella pertussis toxin (Kohno et al., 1983; Doncel et al., 1989). 
 
The initial phase of EAO involves the production of auto-antibodies against testicular 
antigens, increased migration and infiltration of leukocytes such as macrophages, CD4+ 
and CD8+ effector T cells and dendritic cells as well as the elevated production of pro-
inflammatory cytokines like COX-2, IFNγ, TNFα and IL-6 or chemokines such as 
MCP-1 (Fijak et al., 2005; Iosub et al., 2006; Rival et al., 2006, 2008; Nicolas et al., 
2017). The chronic phase of the disease consists of granuloma formation, progressive 
apoptosis of germ cells and shrinkage of seminiferous tubules, which can finally result 
in a complete absence of spermatogenesis and consequently decreased testicular weight 
(Guazzone et al., 2003, Fijak et al., 2011a). Comparable pathological changes were 
found in testicular biopsies from patients with chronic orchitis (Duan et al., 2011; Aslani 
et al., 2015; Nicolas et al., 2017). Although the population of immunoregulatory T cells 
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such as CD4+CD25+Foxp3+ T cells (Treg) and CD8+Foxp3+ T cells is increased in 
inflamed testes, these cells were not able to suppress the inflammatory reaction and 
maintain organ homeostasis (Jacobo et al., 2009, 2015; Fijak et al., 2011b). Specifically, 
M1 macrophages expressing MHC class II, CD80 and CD86 costimulatory molecules as 
well as pro-inflammatory cytokines (IL-6 and TNFα) are much increased and thus 
develop as the main macrophage population in EAO testes (Rival et al., 2008). This 
observation was accompanied by elevated expression of MCP-1 (Aslani et al., 2015; 
Nicolas et al., 2017). Besides cytokines and chemokines, molecules, like HMGB1, are 
also playing in testicular inflammation in human and rat. In this regard, blockade of 
upregulated HMGB1 by ethyl pyruvate after induction of EAO reduces disease 
progression and spermatogenic damage as documented by lower numbers of interstitial 
macrophages as well as decreased IL-6 mRNA expression levels (Aslani et al., 2015).    
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1.6. Aim of the study  
 
The testis is an immune privileged organ, where the somatic (mostly Sertoli and 
peritubular cells) and immune cells act collectively together to maintain an anti-
inflammatory environment. Paradoxically, about 15% of all male infertility cases are 
related to testicular inflammation. Gal-1 plays a prominent role in the maintenance of 
immune homeostasis by binding to N-acetyllactosamine-containing oligosaccharides on 
the cellular surface. Its wide immune inhibitory capacity ranges from reduction of 
pathogenic Th1 and Th17 cell responses, promotion of Treg cell differentiation and 
polarization of M2 macrophages to the expansion of tolerogenic dendritic cells. This 
promoted us to investigate whether Gal-1 is involved in the maintenance of immune 
homeostasis in the testis. 
 
The EAO model represents an in vivo system for studying organ-specific autoimmunity 
and chronic testicular inflammation that reproduces pathological changes also seen in 
some cases of human immunological infertility. 
  
Therefore, the aim of this study was to investigate the expression of Gal-1 in rat EAO 
testes and the involvement of Gal-1 in testicular inflammation. Moreover, the glycan 
profiles in EAO testes and TNFα challenged Sertoli as well as peritubular cells were 
investigated by using lectin binding assay. 
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2. MATERIALS 
2.1. Chemicals 
 
Acetic acid  Merck, Darmstadt, Germany 
Acrylamide 30% (w/v)  Roth, Karlsruhe, Germany 
Agarose  Invitrogen, Karlsruhe, Germany 
Ammonium solution 25%  Merck, Darmstadt, Germany 
Ammonium persulphate (APS) Sigma, Steinheim, Germany 
BlueEasy prestained protein marker Nippon Genetics Europe, 
 Dueren, Germany 
Bromophenol blue sodium salt  Sigma, Steinheim, Germany 
Calcium chloride  Merck, Darmstadt, Germany 
Coomassie Brilliant Blue G-250  Bio-Rad, Munich, Germany 
DAPI mounting media  Vector, Burlingame, USA 
Dimethyl sulfoxide  Merck, Darmstadt, Germany 
Dithiothreitol (DTT) Roth, Karlsruhe 
DNA Ladder (100 bp)  Nippon Genetics Europe, 
 Dueren, Germany 
D-Glucose Sigma, Steinheim, Germany 
1,4-Dithiothreitol  Roche, Mannheim, Germany 
Ethanol  Sigma, Steinheim, Germany 
Ethidium bromide  Roth, Karlsruhe, Germany 
Ethylene diaminetetraacetic acid disodium salt (EDTA) Merck, Darmstadt, Germany 
Glycerol  Merck, Darmstadt, Germany 
Glycine  Sigma, Steinheim, Germany 
Halt Phosphatase Inhibitor Cocktail Thermo Fisher Scientific,  
 Waltham, USA 
Hydrochloric acid 37%  Sigma, Steinheim, Germany 
                                                                                                                        MATERIALS 
  - 31 -  
 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  Roth, Karlsruhe, Germany 
Igepal CA-630 (NP-40)  Sigma, Steinheim, Germany 
Isoflurane  Baxter, Unterschleißheim,  
 Germany 
α-Lactose monohydrate, reagent grade Sigma, Steinheim, Germay 
Mayer's hematoxylin solution  Merck, Darmstadt, Germany 
Methanol  Sigma, Steinheim, Germany 
β-Mercaptoethanol AppliChem, Darmstadt, 
 Germany 
Non-fat dry milk  Roth, Karlsruhe, Germany 
N, N, N`, N`-Tetramethylethylenediamine (TEMED) Roth, Karlsruhe, Germany 
Osmium tetroxide, 99%  Sigma, Steinheim, Germany 
Paraformaldehyde  Merck, Darmstadt, Germany 
Picric acid  Merck, Darmstadt, Germany 
Phenylmethylsulfonyl fluoride (PMSF)  Sigma, Steinheim, Germany 
Ponceau S  Roth, Karlsruhe, Germany 
Potassium chloride  Merck, Darmstadt, Germany 
1, 2- Propylene oxide  Merck, Darmstadt, Germany 
ProLong Gold Antifade Mountant with DAPI Thermo Fisher Scientific,  
 Waltham, USA 
Propidium iodide solution Miltenyi Biotec, Bergisch  
 Gladbach, Germany 
Protease inhibitor cocktail  Sigma, Steinheim, Germany 
Rotiphorese Gel 30  Roth, Karlsruhe, Germany 
Sodium acetate  Roth, Karlsruhe, Germany 
Sodium chloride  Sigma, Steinheim, Germany 
Sodium dodecyl sulfate (SDS)  Merck, Darmstadt, Germany 
Super Signal West Pico chemiluminescent substrate  Thermo Scientific, Waltham,  
 USA 
Tris (hydroxymethyl) aminomethane  Roth, Karlsruhe, Germany 
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Triton X-100  Sigma, Steinheim, Germany 
Tween-20 Roth, Karlsruhe, Germany 
 
2.2. PCR reagents  
 
RNase-Free DNase Set Qiagen, Hilden, Germany 
Desoxy-ribonukleoside triphosphate (dNTP) 10mM Promega, Mannheim, Germany 
iTaq Universal SYBR Green Supermix    Biorad, München, Germany 
Moloney Murine Leukemia Virus Reverse Transcriptase, 
(M-MLV RT) Promega, Mannheim, Germany 
Oligo dT 15 Primer Promega, Mannheim, Germany 
Recombinant RNasin® Ribonuclease Inhibitor Promega, Mannheim, Germany 
Taq polymerase Promega, Mannheim, Germany  
 
2.3. Cell culture reagents and equipment 
 
Bovine serum albumin (endotoxin free) Invitrogen, Karlsruhe, Germany 
Cell culture CO2 incubator Binder, Tullingen, Germany 
Cell strainer, 70μm BD Falcon, NY, USA 
Dulbecco´s PBS (1×) w/o Ca
2+
 & Mg
2+
 Gibco, Darmstadt, Germany  
Fetal bovine serum Gibco, Darmstadt, Germany 
JNK inhibitor Sigma, Steinheim, Germay 
Neubauer counting chamber  Boeco, Hamburg, Germany 
Penicillin/Streptomycin (100×) Gibco, Darmstadt, Germany  
p38 inhibitor Sigma, Steinheim, Germay 
RPMI 1640 medium Gibco, Darmstadt, Germany  
Sterile plastic ware for cell culture Sarstedt, Nümbrecht, Germany 
Trypsin/EDTA Gibco, Darmstadt, Germany  
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2.4. Miscellaneous 
 
Enhanced chemiluminescence (ECL) reagents Thermo Fisher Scientific, 
 Waltham, USA 
Entellan ®Neu Merck, Darmstadt, Germany 
Hybond ECL nitrocellulose membrane Amersham, Freiburg, Germany 
Nitrocellulose membrane (0.2 µm pore size)  GE Healthcare, Freiburg,  
 Germany 
RNeasy Mini Kit Qiagen, Hilden, Germany 
Pierce BCA Protein Assay Thermo Fisher Scientific, 
 Waltham, USA 
 
2.5. Software 
 
Bio-Rad CFX Manager 3.1 Bio-Rad, Munich, Germany 
FlowJo V10 FlowJo LLC, Oregon, USA 
FusionCapt Advance software Witec Ag, Luzern, Switzerland 
GraphPad Prism 5 GraphPad Software, San Diego,  
 USA 
Zeiss AxioVision software 4.8 Carl Zeiss, Göttingen, Germany 
 
2.6. Equipment 
 
Centrifuge (5424R)  Eppendorf, Hamburg, Germany 
CFX96 Touch thermal cycler Bio-Rad, Munich, Germany 
Cryostat CM30509  Leica, Wetzlar, Germany 
Desktop centrifuge Biofuge Fresco Heraeus, Hanau, Germany 
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Electronic balance SPB50 Ohaus, Giessen, Germany 
Fluorescent microscope Axioplan 2 Imaging Carl Zeiss, Göttingen, Germany 
Fusion FX7  Witec Ag, Luzern, Switzerland 
Gel Jet Imager 2000 documentation system Intas, Göttingen, Germany 
Heat block DB-2A Techne, Cambridge, UK 
Horizontal mini electrophoresis system PEQLAB, Erlangen, Germany 
Labofuge 400R  Heraeus, Hanau, Germany 
MACS Quant 10 flow cytometer  Miltenyi Biotec, Bergisch  
 Gladbach, Germany 
Microplate ELISA reader (Multiscan RC)  Labsystems, Vantaa, Finland  
Microwave oven Samsung, Schwalbach,  
 Germany 
Mini centrifuge Galaxy VWR International, Germany 
Mini-rocker shaker MR-1 PEQLAB, Erlangen, Germany 
Mixer Mill MM 300 Retsch, Haan, Germany 
NanoDrop ND 2000 Thermo Fisher Scientific,  
 Waltham, USA 
PCR thermocycler Biozyme, Oldendor, Germany 
Power supply units PEQLAB, Erlangen, Germany 
Pre-cast gel system Invitrogen, Karlsruhe, Germany 
SDS gel electrophoresis chambers Consurs, Reiskirchen, Germany 
Semi-dry electroblotter Bio-Rad, Munich, Germany 
Stainless steel beads, 5mm (#69989)  Qiagen, Hilden, Germany 
SuperFrost Plus microscope slides  R.Langenbrinck, Emmendingen,  
 Germany 
Tips and tubes  Sarstedt, Nümbrecht, Germany 
Thermo Shaker PEQLAB, Erlangen, Germany 
Vertical electrophoresis system PEQLAB, Erlangen, Germany 
UV visible spectrophotometer Ultrospec 2100 Pro  Biochrom, Cambridge, UK 
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3. METHODS 
* Details of antibodies, primers, lectins, enzymes, buffers and solutions are listed in the 
appendix. 
3.1. Animals 
 
19 day old rats were used for Sertoli and peritubular cell isolation. Adult male Wistar 
rats (Charles River Laboratories, Sulzfeld, Germany) aged 60 - 70 days were used for 
EAO induction. All the experiments involving animals were carried out in strict 
accordance with the recommendations in the Guide for the Care and Use of Laboratory 
Animals of the German law of animal welfare. For Sertoli and peritubular cell isolation, 
male rats were killed by CO2 inhalation. During immunization procedure, rats were 
anaesthetized by intraperitoneal administration of 100 mg/kg b.w. ketamine and 10 
mg/kg b.w. xylazine. All efforts were made to alleviate the suffering of animals. 
 
3.2. Induction of EAO 
 
To induce EAO, adult male Wistar rats (Charles River Laboratories, Sulzfeld, Germany) 
aged 60–70 days were immunized with testicular homogenate in complete Freund`s 
adjuvant as previously described (Aslani et al., 2015). Briefly, animals were injected 
with testicular homogenate in complete Freund’s adjuvant, followed by i.v. injection of 
inactivated Bordetella pertussis bacteria three times every 14 days (Figure 6). Control 
animals received 0.9% NaCl instead of testicular homogenate in complete Freund`s 
adjuvant. Normal untreated rats were also included. Animals were sacrificed 50 days 
after the first immunization, testes were removed and frozen in liquid nitrogen. All 
animal experiments were approved by the local animal ethics committee 
(Regierungspraesidium Giessen GI 20/23 – Nr. 33/2008). 
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Figure 6. Schematic diagram illustrating induction of EAO in Wistar rats by active 
immunization with testicular homogenate (TH) in complete Freund’s adjuvant followed 
by i.v. injection of inactivated Bordetella pertussis bacteria. Control adjuvant animals 
received saline instead of TH.  
 
3.3. Hematoxylin-eosin staining 
 
10 μm thick frozen sections were cut using a cryostat. Frozen samples were rehydrated 
through a series of decreasing ethanol concentrations starting from 100% to 40%, for 3 
min each step and rinsed in deionized H2O (dH2O). Samples were stained with Mayer's 
hematoxylin solution for 5 min, left under flowing tap water for 10 min and rinsed with 
dH2O for 5 min. Then samples were stained in 0.5% eosin solution containing acetic 
acid (2 drops in 100 ml solution) for 1-2 min and rinsed in dH2O again. Subsequently, 
sections were dehydrated in increasing alcohol series starting from 40% to 100% for 3-5 
min, and then rinsed in xylene for 2 × 5 min. Finally, sections were mounted using 
Entellan ®Neu (Merck, Darmstadt, Germany). 
 
3.4. Immunofluorescence microscopy 
 
Testicular cryosections (10 µm) were fixed in methanol (Sigma-Aldrich, Steinheim, 
Germany) at -20°C for 10 min and permeabilized in 0.1% Triton X-100. After blocking 
with 5% goat serum and 2.5% BSA (Carl Roth, Karlsruhe, Germany) in PBS-T (PBS 
containing 0.1% Tween 20), sections were incubated overnight with appropriate primary 
antibody in 2.5% BSA diluted in PBS-T at 4°C. Afterwards sections were washed in 
PBS-T and incubated with secondary antibody in PBS-T at room temperature (RT) for 1 
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h. Finally, sections were mounted with ProLong Gold Antifade Mounting media with 
DAPI (Thermo Fisher Scientific, Waltham, USA). Images were taken with an Axioplan 
2 Zeiss microscope (Carl Zeiss, Göttingen, Germany). 
 
3.5. Lectin binding assay 
 
Testicular cryosections were fixed in 2% paraformaldehyde for 30 min. After blocking 
with 1% BSA in PBS, sections were washed with 0.1% BSA in PBS. Subsequently, 
sections were incubated with a specific lectin conjugated with FITC (EY Laboratories, 
San Mateo, USA) in 1% BSA-PBS for 30 min and rinsed in 0.1% BSA in PBS 3 × 5min. 
Finally, sections were mounted with ProLong Gold Antifade Mounting media with 
DAPI. Images were taken with an Axioplan 2 Zeiss microscope (Carl Zeiss, Jena, 
Germany). 
 
3.6. Isolation of Sertoli and peritubular cells 
 
Sertoli and peritubular cells were isolated from 19-day old Wistar rats. Ten male rats 
were killed by CO2 inhalation. Blood was removed by immediate postmortem incision 
of the jugular veins under flowing tap water. The abdomen was disinfected with 70% 
ethanol and twenty testes were removed aseptically via transabdominal route and 
collected in 20 ml of PBS-A. Testes were rinsed by 20 ml of 1% (w/v) iodine alcohol for 
30 sec to sterilize, and immediately washed two times with PBS-A. Then, the testes were 
decapsulated in a sterile Petri dish and dispersed by enzymatic digestion. 
 
Seminiferous tubules were digested using 10 ml trypsin - DNase solution at 32°C in a 
shaking water bath (120 oscillations/min) for 4-6 min. When seminiferous tubules were 
separated, trypsin digestion was stopped by adding trypsin inhibitor solution A. After 
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settling down of the seminiferous tubules for 5 min the supernatant was discarded and 
10 ml trypsin inhibitor solution B was added. Then seminiferous tubules were washed 
with PBS-A solution 7 times for 8 min each to remove unwanted interstitial cells. After 
washing steps, the seminiferous tubules were digested using collagenase - hyaluronidase 
- Dnase - solution in a shaking water bath (120 oscillations/min) at 32°C for 10-12 min. 
The detachment of peritubular cells from the seminiferous tubules was observed under 
the phase contrast microscope (Figure 7a - b). Then 20 ml PBS-A was added to the 
digested seminiferous tubule fragments. After settling down for 10 min, the supernatant 
with enriched peritubular cells was carefully collected. 20 ml peritubular cell medium 
was added and the resulting cell suspension was centrifuged at 280 g for 10 min without 
break. The peritubular cell pellet was dissolved in 20 ml peritubular cell medium and 
then seeded in 5 flasks containing 16 ml peritubular cell medium. Peritubular cells were 
passaged after 3 days` incubation. For treatment, peritubular cells were seeded into 6-
well plates (5×105 cells/well). 
 
For Sertoli cell isolation, the remaining seminiferous tubules were washed 4 times using 
PBS-A solution. Subsequently, the tubules were further digested by using 10 ml of 
hyaluronidase-DNase-solution at 32°C in a shaking water bath (120 oscillations/min) for 
7-10 min, until short tubule fragments and released cells were visible (Figure 7c - d). 
The fragmented tubules were allowed to settle for 12 min and washed 4 times with PBS-
A to remove contaminating germ and peritubular cells. The fragments were dispersed by 
passing 10 times through an 18G needle using a 20 ml syringe, followed by 
centrifugation at 300 × g for 10 min. After resuspending with 40 ml Sertoli cell medium, 
cells were passed through 70 µm nylon filter (BD Biosciences, Heidelberg, Germany) to 
get rid of undigested tubular fragments. Cells were counted using the Neubauer counting 
chamber (Boeco, Hamburg, Germany). Finally, 2 × 106 cells/well were seeded in 6-well 
plates and incubated at 32°C with 5% CO2. After two-day culture hypotonic shock 
treatment by using 20 mM Tris-HCl (pH 7.5) for 1.5 min was performed to remove 
contaminating germ cells (Figure 7e). On day 4, a highly purified population of Sertoli 
cells was ready for further experiments (Figure 7f).  
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Figure 7. Isolation of peritubular and Sertoli cells from immature rat testes. The 
enzymatic digestion of testicular parenchyma with collagenase, hyaluronidase and 
DNase I led to detachment of peritubular cells (indicated by arrows) while the lamina 
propria of tubules was still intact as shown at 100x (a) and 400x (b) magnification. 
Subsequently, the seminiferous tubules became fragmented (c) and release of Sertoli 
cells was visible (arrows) (d). After two days, Sertoli cell culture still contained 
contaminating cells (e). A pure population of Sertoli cells was achieved after hypotonic 
shock (f).  
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By immunofluorescence using antibodies directed against α smooth muscle actin and 
vimentin, the purity of Sertoli (Figure 8a and 8b) and peritubular cell (Figure 8c and 8d) 
populations, respectively, were estimated > 95%. 
 
 
 
Figure 8. The purity of primary Sertoli and peritubular cells was analyzed by 
immunostaining. Double staining of vimentin (orange) and α smooth muscle actin 
(green) in Sertoli cell culture (a) after hypotonic shock displayed very high purity with 
only a few contaminating peritubular cells (white arrows) visible. Cultured peritubular 
cells (c) after passaging show no contaminating Sertoli cells. The negative control with 
omission of primary antibodies for Sertoli (vimentin; b) and peritubular cells (α smooth 
muscle actin; d) displayed no staining.  
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3.7. Western blotting 
  
Western blotting is a technique applied to analyze the expression of proteins in tissue 
homogenates or cell extracts by using antibodies specifically targeting the desired 
protein. Frozen rat testes or Sertoli cells were collected into RIPA lysis buffer 
supplemented with proteinase inhibitor cocktail and Halt Phosphatase Inhibitor Single-
Use Cocktail and homogenized using stainless steel beads and a tissue lyser (Qiagen, 
Hilden, Germany) at 30 oscillations/second for 5 min. The protein concentration was 
measured by using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, 
Waltham, USA). Twenty µg protein of each sample were separated by SDS-
polyacrylamide gel electrophoresis for about 2 h at 120 V. Separated proteins were 
electroblotted onto a 0.2 µm pore size nitrocellulose membrane (GE Healthcare, 
Freiburg, Germany) by using a semidry electroblotter (Bio-Rad, Munich, Germany) for 
30 min at 100 mA. The efficiency of the transfer was checked by staining the membrane 
with Ponceau S solution for 10 s. Then membranes were washed in TBS containing 0.1% 
Tween (TBS-T). After incubation in blocking buffer (5% non-fat milk/TBS-T or 5% 
BSA/TBS-T (in case of phosphoprotein detection)) for 1 h at RT, the membranes were 
probed overnight with primary antibodies diluted in blocking buffer at 4°C. 
Subsequently, membranes were washed three times with TBS-T, and then incubated 
with HRP-conjugated anti-mouse or anti-rabbit secondary antibody in 5% non-fat milk 
diluted in TBS-T for 1 h at RT. Afterwards, the membranes were washed again three 
times in TBS-T. The blots were developed by using Hybond ECL (Amersham, Freiburg, 
Germany) and visualized by using the Fusion Imaging system (Witec Ag, Luzern, 
Switzerland). 
 
In order to perform additional antibody detection on the same membrane, membranes 
were incubated with stripping buffer for 3 min at 60°C after washing once with TBS-T. 
The membranes were washed again three times in TBS-T and blocked in 5% non-fat 
milk for 1 h at RT. Subsequently, the procedures like antibody incubation and 
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visualization were performed as described above. 
 
3.8. cDNA synthesis and real-time polymerase chain reaction 
(real-time PCR) 
3.8.1. Extraction of RNA 
    
Total RNA was isolated from fresh cells or frozen rat testes by using the RNeasy Mini 
kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. Briefly, less 
than 5 mg of tissue or 5 × 10
5
 cells were homogenized with 350 μl RLT lysis buffer 
(containing 1% β-mercaptoethanol) by using stainless steel beads and a tissue lyser 
(Qiagen, Hilden, Germany) at 30 oscillations/second for 3 min. Cell or tissue lysates 
were collected after centrifugation for 12 min at 12,000 x g and equal volume of 70% 
ethanol was added and mixed well. Up to 700 µl of the mixture was transferred to 
RNeasy mini spin column and centrifuged at 10,000 × g for 1 min. The flow-through 
was discarded and columns were washed with 350 ml RW1 buffer. Then genomic DNA 
digestion was performed on column by using DNase I (Qiagen, Hilden, Germany) as 
follows: 10 μl DNase I stock solution was added to 70 μl provided RDD buffer. 
Afterwards, 80 μl of the DNase solution was added to the column and incubated for 30 
min at RT. Subsequently, 350 µl RW1 buffer was used to wash column membrane again. 
Then columns were washed twice with provided RPE buffer (containing 90% ethanol) to 
precipitate RNA followed by a centrifugation at 12,000 × g for 2 min to dry the 
membrane. The collection tube was replaced by a new tube and 30 µl RNase-free water 
was directly added to the column membrane. After incubation for 1 min, the RNA was 
eluted by centrifugation at 12,000 × g for 2 min. RNA concentration of each sample was 
measured using the NanoDrop ND2000 (Promega, Mannheim, Germany). 
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3.8.2. Test for genomic DNA contamination 
3.8.2.1. Amplification of a housekeeping gene β-actin 
 
To test a possible genomic DNA contamination, isolated RNA samples were used as 
template for amplification of a housekeeping gene (β-actin) transcription. A typical PCR 
mix is shown in Table 1.  
 
Table 1. PCR reaction mix. 
Reagents Volume 
RNA 1 µl 
5 × Green Go Taq Flexi Buffer 5 µl 
MgCl2 25 mM 2 µl 
dNTP 10 mM 0.5 µl 
Go Taq Polymerase Flexi 0.25 µl 
H2O 15.25 µl 
Reverse primer 10 pM 0.5 µl 
Forward primer 10 pM 0.5 µl 
Total volume 25 µl 
 
PCR was run on a PCR thermocycler (PeqLab, Erlangen, Germany) for 25 cycles as 
shown in Table 2. 
 
Table 2. PCR conditions for β-actin amplification. 
Number of 
cycles 
Temperature (°C) PCR step Time 
1 94 Denaturation 4 min 
 
25 
94 Denaturation 40 sec 
55 Annealing 40 sec 
72 Elongation 40 sec 
1 72 Enzyme deactivation 10 min 
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3.8.2.2. Agarose gel electrophoresis 
 
1.5 g of agarose was completely dissolved in 100 ml TAE buffer. Ethidium bromide 
solution (Roth, Karlsruhe, Germany; 2 drops/100 ml) was added to the agarose solution 
for detection of nucleic acids and gels were casted. A 100 bp DNA ladder (Promega, 
Mannheim, Germany) and samples from β-actin amplification were loaded. Then gel 
was run at 100 V (2-10 V/cm gel) in TAE buffer for 20 min. Finally, agarose gels were 
examined on a UV transilluminator and photographed using a gel jet imager 2000 
documentation system (Intas, Göttingen, Germany). cDNA used as positive control 
displayed a β-actin transcript at the expected size of 232 bp. No amplification product 
was detected in negative control with H2O instead of RNA and isolated RNA samples, 
indicating no presence of genomic DNA contamination in the extracted RNA samples 
(Figure 9). Only RNA samples without genomic DNA contamination were used for the 
following experiments.  
 
 
Figure 9. Representative agarose gel with PCR products for testing genomic DNA 
contamination. Positive control (P) containing testicular cDNA displayed a β-actin 
transcript at the expected size of 232 bp. No β-actin transcripts were detected in negative 
control (N) and RNA samples extracted from untreated testis (R1), adjuvant testis (R2) 
and EAO testis (R3). (L: 100 bp DNA ladder). 
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3.8.3. Reverse transcription PCR (RT-PCR) 
 
The RNA samples without genomic DNA contamination were reverse transcribed by 
using M-MLV reverse transcriptase RNase (H-), point mutant (Promega, Mannheim, 
Germany). For each reverse transcription reaction 2 µg of RNA was used. RT-PCR mix 
(Table 3) was denatured for 10 min at 70°C. 
  
Table 3. Composition of RT-PCR mix. 
Reagents Volume 
RNA Calculated volume 
Oligo dT concentration (10 pM) 2 µl 
H2O X µl 
Total volume 22 µl 
X = 20 µl – volume of RNA 
 
In another reaction set up master mix (Table 4) was pre-warmed for 2 min at 42°C. 
Afterwards 18 µl of denatured RNA were mixed with 22 µl of RT-PCR master mix with 
addition of 1 µl of M-MLV reverse transcriptase. The samples were reverse transcribed 
at 42°C for 75 min, followed by inactivation of reverse transcriptase by incubating the 
samples at 70°C for 15 min. For further use cDNA samples were stored at -20°C. 
 
Table 4. RT-PCR master mix. 
Reagents Volume  
5 X RT-PCR buffer 8 µl 
dNTP 10mM 2 µl 
Recombinant RNasin® Ribonuclease Inhibitor (40 u/µl) 1 µl 
H2O 7 µl 
Total volume  18 µl 
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3.8.4. Real-time PCR 
 
Real-time PCR is a widely used technique to monitor and quantify the amplification of a 
targeted gene under real time conditions based on the polymerase chain reaction. The key 
feature of real-time PCR is that fluorescent dyes (e.g. SYBR green) intercalated in "real 
time" with the double stranded DNA (amplified products). Real-time PCR was performed 
by using CFX TouchTM Real-Time PCR detection system (Bio-Rad, Munich, Germany). 
The primers for rat galectin-1 (Lgals1), mannoside acetylglucosaminyltransferase 5 
(Mgat5), core 2 glucosaminyl (N-acetyl) transferase 1 (Gcnt1), and ST6 beta-galactoside 
α-2-6-sialyltransferase 1 (St6gal1) were purchased as PrimePCR SYBR Green Assays 
from Bio-Rad (Munich, Germany). As housekeeping genes β-actin, hypoxanthine 
guanine phosphoribosyl transferase (Hprt) and 18s rRNA (Rn18s) were used. A typical 20 
µl real- time PCR reaction mix (Table 5) was used as follows.  
 
Table 5. Real-time PCR reaction mix. 
 
 
 
 
 
 
 
    
After Real-time PCR reaction, each targeted gene has a value of cycle threshold (Ct) 
defined as the number of cycles required for the fluorescent signal to cross the threshold. 
Relative gene expression was calculated by using the 2
-ΔΔCt
 method (Livak and 
Schmittgen, 2001). Briefly, the 2
-ΔΔCt
 method is built on calculation of ∆Ct by 
subtracting the Ct value of the housekeeping gene from the Ct value of the targeted gene 
in each sample. Then ΔΔCt is calculated by subtracting the mean of the ΔCt value of the 
Reagents Volume per reaction 
cDNA 1 µl 
2 ×  iTaq™ Universal SYBR® Green Supermix 10 µl 
Forward primer (10 pM) 0.5 µl 
Reverse primer (10 pM) 0.5 µl 
H2O 8 µl 
Total volume 20 µl 
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control samples from the ΔCt value of each sample. Finally, 2-ΔΔCt is representative for 
the relative expression of the gene. Real-time PCR conditions are listed in Table 6. 
  
Table 6. Real-time PCR program 
Cycles Temperature (°C) PCR step Time 
1 95 Denaturation  30 sec 
 
45 
95 Denaturation 15 sec 
55 Annealing 30 sec 
72 Elongation 30 sec 
Melt curve 50 - 95 Dissociation 5 sec 
 
In addition during real-time PCR, analysis of the melt curve was also performed, which 
could assess the dissociation characteristics of double-stranded DNA during heating. 
When the temperature gets raised, double DNA strand starts to dissociate and then the 
inserted SYBR green fluorescent dye is released, leading to a decrease of the emitted 
fluorescent signal. The melt curve was obtained from a function of temperature plotted 
by the change in slope of the fluorescence curve. The melt curve analysis was used to 
monitor whether only one specific PCR product was produced during the target gene 
amplification. A single peak of the melt curve represents one single product. Figure 10 
shows a representative melt curve for all the studied real-time PCR. 
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Figure 10. Representative melt curves from real-time PCR of Hprt amplification. 
The single peak represents one single product. 
 
3.9. Measurement of lectin binding to Sertoli and peritubular 
cells by flow cytometry 
 
A total of 2 x 10
5
 Sertoli or peritubular cells were used for the lectin binding assay. After 
washing with 1% BSA in PBS, cells were incubated for 1 h at RT with 50 µl of the 
corresponding plant lectin solution. Afterwards the cells were washed 3 times with 1% 
BSA in PBS. In order to exclude dead cells propidium iodide (PI) was added before the 
measurement and samples were analyzed with a MACSQuant 10 flow cytometer 
(Miltenyi Biotec, Bergisch Gladbach, Germany). Data were collected from 20,000 
events and analyzed with FlowJo soſtware version 10.0.8 (Ashland, Oregon, USA). 
 
The gating strategy is presented below (Figure 11). After gating out cell debris, doublets 
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and non-viable cells (Figure 11a - c), the cells binding a specific lectin were selected in 
the FITC channel (Figure 11d). For further analysis, the median of fluorescence intensity 
from each lectin binding experiment were collected. 
 
 
Figure 11. The gating strategy for flow cytometric analysis of lectin binding to 
Sertoli and peritubular cells. Detected cells were displayed by using forward scatter 
(FSC) and side scatter (SSC) (a). Doublets (b), cell debris and non-viable cells (c) were 
gated out. The FITC channel was selected to show indicated lectin binding (d). 
 
3.10. Statistical analysis 
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Data are shown as mean ± SEM. Comparisons of lectin binding in untreated and TNFα 
treated cells were performed by a two-tailed t-test. One-way ANOVA followed by 
Tukey’s multiple comparison post hoc tests were applied when more than two groups 
were compared. P-values < 0.05 were considered as statistically significant. All tests 
were performed using GraphPad Prism 5 software (GraphPad Software, San Diego, 
USA). 
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4. RESULTS 
4.1. Histopathological changes in rat EAO 
 
Fifty days after the first immunization 70% (7/10) of the animals manifested chronic 
testicular inflammation. EAO was evaluated by means of histopathological alterations and 
reduced testicular weight (Fijak et al., 2005). Pathological changes in the testis included 
strong infiltration of the interstitium by leukocytes and cell loss in the germinal epithelium 
(Figure 12c) that was accompanied by a reduced testicular weight (Aslani et al., 2015). 
Testes from untreated and adjuvant controls showed a completely normal morphology 
(Figure 12a and 12b).  
 
 
Figure 12. Testicular histopathological changes in EAO. Hematoxylin-eosin (HE) staining 
in cryostat sections from normal (a), adjuvant control (b) and EAO (c) rat testes. 
 
4.2. Gal-1 is mainly expressed in Sertoli and germ cells 
 
Immunofluorescence staining revealed that in normal testis Gal-1 was localized in 
seminiferous tubules, mainly in germ cells and in the cytoplasm of Sertoli cells as co-
localization with vimentin showed (Figure 13a - d). In normal testis Gal-1 was detected in the 
basal and apical cytoplasm of Sertoli cells (Figure 13b and 13d). As shown in Figure 13e and 
13f in inflamed testis only Sertoli cells expressed Gal-1 in otherwise 'empty' tubules depleted 
of germ cells. 
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Figure 13. In normal rat testes Gal-1 is expressed mainly in Sertoli cells and germ cells. 
Localization of Gal-1 (Alexa 546, orange) in normal (a and b), adjuvant control (c and d) and 
EAO (e and f) testis. Vimentin (Alexa 488, green) was used as a marker of Sertoli cells. Right 
panels (b, d and f) show magnified areas in boxes (a, c and e), which display stained Gal-1 
(Alexa 546, orange) in germ cells (thin arrow) and Sertoli cells (thick arrow) (b, d and f). 
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4.3. CD68+ macrophages in the vicinity of granulomas express 
Gal-1 in inflamed testes 
 
To examine a possible localization of Gal-1 in testicular macrophages, two different 
macrophage makers (CD68 and CD163) were applied using double immunofluorescence. Co-
staining revealed that in normal testes CD68+ macrophages were not positive for Gal-1 
(Figure 14a and 14c). Interestingly, in inflamed testis Gal-1 was detected in a few CD68+ 
macrophages located in the vicinity of granulomas (Figure 14e and 14g). Of note, the 
expression of Gal-1 was not observed in CD163+ macrophages, both in normal and EAO 
testes (Figure 14b, 14d, 14f and 14h). 
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Figure 14. CD68+ macrophages around granulomas express Gal-1 in inflamed testes. 
Localization of Gal-1 (Alexa 546, orange) in normal (a and b), adjuvant control (c and d) and 
EAO (e - h) testes. Staining of Gal-1 and CD68 (Alexa 488, green) or CD163 (Alexa 488, 
green) in the region of granulomas (g, h). Testicular macrophages were stained with CD68 
and CD163 antibodies. Gal-1 was expressed in some CD68+ macrophages (g) found around 
granulomas (thick arrows), but not in CD163+ macrophages (h; thin arrows). 
 
4.4. Expression of Gal-1 in EAO testis is decreased due to germ 
cell loss 
 
In order to investigate testicular expression of Gal-1 in the EAO model, testes from untreated, 
adjuvant control and EAO rats were processed for Western blot and real-time PCR analyses. 
Gal-1 protein levels in EAO testes were downregulated as compared to normal and adjuvant 
control testes (Figure 15a - b). Similarly, relative expression of Gal-1 mRNA was also 
reduced in inflamed testes (Figure 15c). Because the ratio of testicular cell types in EAO 
testis is changed due to the loss of germ cells and infiltration of immune cells, the relative 
expression of Gal-1 mRNA was also normalized to the Sertoli cell specific transcript Sox9 
(Figure 15d). These data indicate that the mRNA expression of endogenous Gal-1 in Sertoli 
cells was not changed in EAO testis as compared to control testis at the investigated time 
point.  
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Figure 15. Changes in the expression of Gal-1 in EAO testes are due to germ cell loss. 
Western blot (a) and densitometric (b) analysis of Gal-1 expression in testes from untreated, 
adjuvant control and EAO animals. Gal-1 mRNA relative expression (RE) was normalized to 
three housekeeping genes (β-actin, Hprt and 18s rRNA) (c) or Sertoli cell marker Sox9 (d). (n 
= 5, * P<0.05, ** P<0.01, *** P<0.001). 
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4.5. Increase of St6gal1 mRNA expression and terminal α-2-6-
sialylation in EAO testis 
 
Gal-1 binds to N-acetyllactosamine (LacNAc) present on branches of N- and O-glycans on 
the cell surface (Cedeno-Laurent and Dimitroff, 2012). There are three important post-
translational mechanisms to form Gal-1 binding sites including: (a) activity of core 2 
glucosaminyl (N-acetyl) transferase 1 (Gcnt1) for the synthesis of core 2 O-glycans, which 
built the backbone of Gal-1 ligands, (b) suppression of ST6 beta-galactoside α-2-6-
sialyltransferase 1 (St6gal1) activity, that abrogates Gal-1 binding to some terminal N-
acetylglucosamines by adding α-2-6-sialic acid and (c) branching of N-glycans by mannosyl 
(α-1,3-)-glycoprotein ß-1,2-N-acetylglucosaminyltransferases (Mgat) like Mgat5 (Figure 16a) 
(Cedeno-Laurent and Dimitroff, 2012).  
 
The results showed that the level of St6gal1 mRNA in EAO testes was upregulated (Figure 
16b). In contrast, Mgat5 mRNA expression was downregulated as compared to control testes 
(Figure 16c).  
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Figure 16. Expression analysis of transferases involved in glycan biosynthesis in EAO 
testes. (a) Schematic representation of N- and O-glycan biosynthesis. St6gal1 (b), Mgat5 (c) 
and Gcnt1 (d) relative mRNA expression was normalized to β-actin, Hprt and 18s rRNA. (n = 
5, ** P<0.01, *** P<0.001). 
 
At the same time, binding of SNA, that recognizes terminal α-2-6 sialic acid residues (red 
triangles in Figure 16a), was increased as compared to untreated and adjuvant control testis 
(Figure 17a - c). In contrast, binding of Phaseolus vulgaris agglutinin (L-PHA), that 
recognizes ß-5-ß-4-N-acetyl–glucosamine (blue squares in Figure 16a), was reduced in EAO 
testis (Figure 17d - f). These data indicate that α-2-6-sialylation of O- and N-glycans is 
elevated in inflamed testis. Notably, expression of Gcnt1 mRNA was unchanged (Figure 
16d), whereas binding of peanut agglutinin (PNA), that recognizes asialo-galactose ß-1-3-N-
acetylgalactosamine (core-1) in O-glycans, was decreased in EAO testis (Figure 17g - i). 
However, we did not observe any significant change in the binding of MAA, that is 
recognizing NeuNAcα (2-3) Galβ (1-4) GlcNAc/Glc, in EAO testis (Figure 17j - l). 
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Figure 17. Expression analysis of lectin-FITC binding in EAO testes. Binding of FITC 
labeled SNA (a - c), L-PHA (d - f), PNA (g - i), and MAA (j - l) to testicular sections from 
untreated (a, d, g and j), adjuvant control (b, e, h and k) and EAO (c, f, i and l) animals. 
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4.6. The binding of SNA to Sertoli and peritubular cells is 
increased after TNFα stimulation, whereas binding of L-PHA is 
decreased 
 
Since inflammatory conditions influence the glycophenotype of cells, we investigated the 
binding of different lectins that selectively recognize specific oligosaccharide structures to 
TNFα stimulated primary Sertoli and peritubular cells by flow cytometry (Figure 18a). The 
binding of SNA to Sertoli (Figure 18a, b) and peritubular cells (Figure 18a, c) challenged by 
TNFα was significantly increased compared to untreated cells. In contrast, the binding of L-
PHA to TNFα stimulated Sertoli cells (Figure 18b) and peritubular cells (Figure 18c) was 
significantly reduced as compared to control cells. Increased binding of MAA was only found 
in TNFα stimulated Sertoli cells, whereas the binding of PNA to stimulated Sertoli and 
peritubular cells was unchanged (Figure 18b - c). 
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Figure 18. Influence of TNFα stimulation on the glycan profile of Sertoli and 
peritubular cells. (a) Flow cytometric analysis of cell-surface glycans in Sertoli and 
peritubular cells after stimulation with 25 ng/ml TNFα was detected by staining cells with 
FITC-labeled lectins (SNA, MAA, L-PHA, or PNA) (black filled histograms) or without 
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(open histograms). Numbers in the upper-right corner represent the median of fluorescence 
intensity. The binding of FITC-labelled lectins to Sertoli (b) or peritubular cells (c) was 
quantified as relative median fluorescence intensity (rMFI); (rMFI = (MFI with lectin – MFI 
without lectin)/MFI without lectin) (n = 3-5, * P<0.05, ** P<0.01, *** P<0.001).  
 
4.7. Gal-1 is upregulated in Sertoli cells after TNFα stimulation 
 
The inflammatory cytokine TNFα is highly upregulated in EAO testis (Theas et al., 2008; 
Aslani et al., 2015). To examine the influence of an inflammatory environment on Gal-1 
expression, TNFα was used to stimulate primary Sertoli cells. After stimulation, a dose-
dependent increase in Gal-1 expression was observed in Sertoli cells as compared to 
untreated cells (Figure 19). 
 
Figure 19. Analysis of Gal-1 expression in primary Sertoli cells. Western blot (a) and 
densitometric (b) analysis of Gal-1 expression in primary Sertoli cells after TNFα 
stimulation. (n = 5, * P<0.05).  
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4.8. Gal-1 and TNFα synergistically induce an inflammatory 
response in Sertoli cells 
 
To determine whether binding of Gal-1 to Sertoli cells can modulate the inflammatory 
response, we analyzed expression of inflammatory cytokines in TNFα-stimulated (25 ng/ml) 
Sertoli cells and stimulated cells that were pretreated with Gal-1 (5 µg/ml). In Sertoli cells 
treated with TNFα only, mRNA expression levels of IL-1α (Figure 20a), MCP1 (Figure 20c) 
and IL-6 (Figure 20e) were increased. In contrast, mRNA expression of TGFβ2 was not 
affected after TNFα stimulation as compared to untreated cells, although it was increased 
when compared to stimulation with Gal-1 alone (Figure 20d). Pretreatment of Sertoli cells 
with recombinant Gal-1 prior to the addition of TNFα synergistically induced expression of 
IL-1α, TNFα, MCP1, and IL-6 mRNA (Figure 20a – c, e). These effects were abrogated by 
the addition of lactose to the Gal-1 solution 5 min prior to stimulation of Sertoli cells. Of note, 
Sertoli cells did not respond with an inflammatory response after treatment with Gal-1 alone 
(Figure 20). 
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Figure 20. Gal-1 and TNFα act synergistically on the expression of pro-inflammatory 
mediators in Sertoli cells. Primary Sertoli cells were pretreated with Gal-1 (5 µg/ml) for 2h, 
and then stimulated with TNFα (25 ng/ml) for 6h. Lactose (Lac, 50 mM) was used as an 
inhibitor of Gal-1 binding. Relative mRNA expression of IL-1α (a), TNFα (b), MCP1 (c), 
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TGFβ2 (d), and IL-6 (e) was normalized to Hprt; (n = 3-5, * P<0.05, ** P<0.01, *** 
P<0.001).  
 
4.9. Gal-1 and TNFα synergistically activate phosphorylation of 
MAPK p38 and JNK 
 
To better understand the mechanisms underlying the synergistic effects of Gal-1 and TNFα 
on the expression of pro-inflammatory cytokines IL-1α and MCP1, we evaluated the 
activation kinetics of mitogen-activated protein kinases (MAPK) in Sertoli cells following 
TNFα and Gal-1 treatment. Sertoli cells stimulated with TNFα showed increased 
phosphorylation of p38 and JNK from 15-30 min after stimulation (Figure 21a, lanes 2 and 3). 
Interestingly, pretreatment of Sertoli cells with Gal-1 prior to TNFα stimulation 
synergistically enhanced phosphorylation of p38 and JNK 15-30 min after stimulation 
(Figure 21a, compare lanes 2 and 3 with lanes 7 and 8; Figure 21c and d).  
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Figure 21. Effects of Gal-1 and TNFα on MAPK phosphorylation in Sertoli cells. (a) 
Isolated Sertoli cells were pretreated with Gal-1 (5 μg/ml; 2h) and then stimulated with TNFα 
(25 ng/ml) for 0-120 min. Subsequently, phosphorylation of MAP kinases ERK1/2, p38 and 
JNK was investigated by Western blotting. Densitometric analysis of ERK1/2 (b), p38 (c) and 
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JNK (d) phosphorylation in primary Sertoli cells after TNFα and Gal-1 stimulation (n = 3, * 
P<0.05). 
 
In contrast, no activation of MAPK was detected when Sertoli cells were treated with Gal-1 
alone (Figure 22a, compare lanes 1 and 2, and 6 and 7). Gal-1 induced phosphorylation of 
p38 and JNK in the presence of TNFα was specific, because the effect could be abrogated by 
adding 50 mM lactose (Figure 22a, lanes 5 and 10, Figure 22d, e, g). 
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Figure 22. Lactose abrogates effects of Gal-1 on MAPK phosphorylation in TNFα 
treated Sertoli cells. (a) Gal-1 was pre-incubated with lactose (50 mM) for 5 min prior to 
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addition to Sertoli cells. After 2 h Sertoli cells were stimulated with TNFα (25 ng/ml) for the 
indicated times. Subsequently phosphorylation of MAP kinases ERK1/2, p38 and JNK was 
investigated by Western blotting. Densitometric analyses of Figure 22a are shown in Figure 
22b – g. Stimulation with TNFα was for 15 min (b, d, f) or 30 min (c, e, g); (n = 3-4, * 
P<0.05, ** P<0.01, *** P<0.001, **** P<0.0001). 
 
4.10. Treatment of Sertoli cells with p38 and JNK inhibitors 
abrogates the Gal-1 and TNFα induced IL-1α, TNFα, IL-6 and 
MCP-1 mRNA expression 
 
In order to determine whether the effect of Gal-1 and TNFα treatment on inflammatory 
cytokine response is induced specifically through the MAPK signaling pathway, we used a 
p38 inhibitor (SB 203580, 5 mM) and a JNK inhibitor (SP600125, 20 mM) during Gal-1 and 
TNFα stimulation. In the presence of both inhibitors the TNFα stimulated mRNA expression 
of IL-1α (Figure 23a), MCP-1 (Figure 23c) and IL-6 (Figure 23e) was completely abrogated. 
Furthermore, the synergistic effects of Gal-1 and TNFα on IL-1α (Figure 23a), TNFα (Figure 
23b), MCP-1 (Figure 23c) and IL-6 (Figure 23e) mRNA expression levels were completely 
reversed. 
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Figure 23. Inhibitors of p38 and JNK MAP kinases reverse the synergistic effect of Gal-
1 and TNFα on expression of inflammatory mediators in Sertoli cells. Primary Sertoli 
cells were pretreated with Gal-1 (5 µg/ml) for 1 h prior to addition of the p38 inhibitor SB 
203580 (5 mM; p38i) and the JNK inhibitor SP600125 (20 mM; JNKi) for 1 h. Afterwards 
Sertoli cells were stimulated with TNFα (25 ng/ml) for 6 h. Relative mRNA expression of 
IL–1α (a), TNFα (b), MCP1 (c), TGFβ2 (d) and IL-6 (e) was normalized to Hprt; (n = 4-7, * 
P<0.05, ** P<0.01, *** P<0.001, **** P<0.0001).  
 
Treatment of Sertoli cells with either the p38 inhibitor alone (Figure 24) or the JNK inhibitor 
alone (Figure 25) considerably reversed synergistic expression of IL-1α, TNFα, MCP1 and 
IL-6 mRNA after induction with Gal-1 and TNFα. 
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Figure 24. Inhibition of JNK MAP kinase partially reversed Gal-1 and TNFα induced 
expression of inflammatory mediators in Sertoli cells. Primary Sertoli cells were 
pretreated with Gal-1 (5 µg/ml) for 1 h prior to addition of JNKi for 1 h. Afterwards Sertoli 
cells were stimulated with TNFα (25 ng/ml) for 6 h. Relative mRNA expression of IL-1α (a), 
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TNFα (b), MCP1 (c), TGFβ2 (d) and IL-6 (e) was normalized to Hprt; (n = 4-7, * P<0.05, ** 
P<0.01, *** P<0.001, **** P<0.0001). 
 
Figure 25. Inhibition of p38 MAP kinase partially reversed Gal-1 and TNFα induced 
expression of inflammatory mediators in Sertoli cells. Primary Sertoli cells were 
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pretreated with Gal-1 (5 µg/ml) for 1 h prior to addition of p38i for 1 h. Afterwards Sertoli 
cells were stimulated with TNFα (25 ng/ml) for 6 h. Relative mRNA expression of IL-1α (a), 
TNFα (b), MCP1 (c), TGFβ2 (d) and IL-6 (e) was normalized to Hprt; (n = 4-7, * P<0.05, ** 
P<0.01, *** P<0.001, **** P<0.0001).  
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5. DISCUSSION 
 
An increasing body of evidence indicates that Gal-1 has immunoregulatory functions in 
autoimmune disease models such as systemic lupus erythematosus, lysolecithin-induced 
demyelination, experimental autoimmune encephalomyelitis (EAE) and experimental arthritis 
(Iqbal et al., 2013; Mari et al., 2016; Rinaldi et al., 2016; Hornung et al., 2017). The 
immunoregulatory characteristics of Gal-1 range from induction of apoptosis in Th1 and 
Th17 cells (Toscano et al., 2007), inhibition of T cell migration (Norling et al., 2008), 
expansion of tolerogenic dendritic cells and regulatory T cells (Toscano et al., 2006; Ilarregui 
et al., 2009),  to maintenance of the maternal-fetal tolerance (Blois et al., 2007). Taking into 
account that Gal-1 is also abundantly expressed in immune privileged organs such as the 
placenta, eye, brain, ovary and testis (Rabinovich and Croci, 2012), we propose that Gal-1 
may play a role in the maintenance of testicular immune privilege. We therefore investigated 
the expression of Gal-1 and relevant glycans in the inflamed testis by using a model of 
experimental autoimmune orchitis and asked whether Gal-1 could modulate the pro-
inflammatory response of Sertoli cells challenged with the archetypal cytokine TNFα. 
 
5.1. Testicular pathological changes in rat EAO 
 
In order to mimic symptoms and pathological changes of human chronic testicular 
inflammation in an animal model, adult male Wistar rats were used to induce EAO. For this 
purpose, a rat EAO model was adopted using testicular homogenate in combination with 
complete Freund’s adjuvant and inactivated Bordetella pertussis bacteria. This protocol has 
been used previously in rats and mice (Doncel et al., 1989; Fijak et al., 2011b; Aslani et al., 
2015; Nicolas et al., 2017). Pathological changes in EAO testis include strong interstitial 
leukocytic infiltration of the interstitium and loss of the germinal epithelium, hallmarks also 
observed in previous studies (Doncel et al., 1989; Fijak et al., 2011b; Aslani et al., 2015). 
Furthermore, the induction rate in this study was comparable to the induction rate mentioned 
in previous studies in rat (Doncel et al., 1989; Fijak et al., 2011b; Aslani et al., 2015).  
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TNFα as a pro-inflammatory cytokine is highly upregulated in EAO testis. The factor is 
mainly produced by testicular macrophages and T lymphocytes, and is thought to play a 
major role in the progression of the disease (Yule and Tung, 1993; Suescun et al., 2003; 
Theas et al., 2008; Aslani et al., 2015). In this regard, administration of TNFα directly to 
adult rat testes can disrupt the integrity of the BTB, impair Sertoli-germ cell adhesion, and 
induce germ cell apoptosis (Li et al., 2006; Theas et al., 2008). In contrast, antibody 
neutralization of TNFα could reduce the incidence and severity of autoimmune orchitis 
induced by adoptive transfer of T cells in mice (Yule and Tung, 1993). More recently, an in 
vitro study showed that the apoptotic effect of conditioned media obtained from testicular 
macrophages in EAO testes on germ cells is abrogated by the selective TNFα blocker 
Etanercept (Theas et al., 2008). Thus, TNFα seems to play an important role in the 
pathogenesis of EAO and was therefore used in this study to mimic testicular inflammatory 
conditions during in vitro treatment of primary testicular cells. 
 
5.2. Gal-1 is expressed in Sertoli cells, germ cells and 
macrophages around granuloma 
 
In line with previous studies (Wollina et al., 1999; Timmons et al., 2002; Dettin et al., 2003; 
Chui et al., 2011), this study also shows that Gal-1 is mainly expressed in Sertoli cells and 
germ cells of the normal rat testis in a stage-specific pattern throughout the spermatogenic 
process. Dettin et al. described that Gal-1 is strongly expressed on apical stalks of Sertoli 
cells and on the head of spermatids during spermiation (stages VI - VIII) and restored at the 
basal part of Sertoli cells after spermiation (Dettin et al., 2003). Martinez et al. found that in 
vitro treatment with recombinant Gal-1 induces Leydig cells apoptosis and thus reduces 
testosterone production in a dose-dependent manner (Martinez et al., 2004). Gal-1 was also 
found in the epididymis where it is associated with sperm maturation (Vasen et al., 2015). 
Exposure of sperm to Gal-1 resulted in an increased percentage of progesterone induced 
acrosome reaction and Gal-1 deficient sperms display defects in their capacity to develop 
hyperactivation a further indicator that Gal-1 is involved in sperm function and fertilization 
(Vasen et al., 2015). 
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In the EAO testis, some CD68+ macrophages in the vicinity of granulomas were positive for 
Gal-1. Since 60-70% of macrophages in granuloma lesions are CD68 positive and local 
macrophage proliferation plays a key role in granuloma formation (Lan et al., 1995), it is 
possible that Gal-1 induces macrophage proliferation and promotes granuloma formation. In 
support, Gal-1 can induce proliferation of vascular endothelial and smooth muscle cells and 
promote fibrosis during chronic pancreatitis/pancreatic cancer (Moiseeva et al., 2000; Kanda 
et al., 2015; Tang et al., 2018). Several studies have also shown that Gal-1 could be involved 
in the resolution of inflammation by regulating inflammatory signaling as well as 
accumulation and phagocytosis of macrophages and microglial cells (Starossom et al., 2012; 
Rostoker et al., 2013; Gaudet et al., 2015). Moreover, Gal-1 can modulate macrophages to a 
pro-regenerative phenotype characterized by increased arginase-1 and reduced IL-6 and 
iNOS production in mouse bone-marrow derived macrophages (Abebayehu et al., 2017). 
Similar to the inflamed testis, Gal-1 expression was limited to macrophages in the vicinity of 
spinal cord lesions (Gaudet et al., 2015). Moreover, Gal-1 was preferentially expressed by 
peritoneal CD11b
high
 macrophages
 
as compared to CD11b
low
 macrophages. The CD11b
high
 
macrophages had a distinct phenotype characterized by a decreased expression of TNFα and 
IL-1β, and increased expression of TGFβ. Expression of Gal-1 declined once the cells were 
converted to the CD11b
low
 phenotype as shown in a mouse peritonitis model (Rostoker et al., 
2013). It can be speculated that Gal-1 facilitates the resolution of macrophage-mediated 
inflammation during peritonitis and may have a similar function during orchitis. 
 
5.3. Downregulation of Gal-1 in orchitis testis is due to germ cell 
loss 
 
Gal-1 was lower expressed in the inflamed testis, whereas its mRNA expression levels did 
not change when real-time PCR results were normalized to the Sertoli cell specific transcript 
Sox9. This suggests that downregulation of Gal-1 in the EAO testis is the consequence of 
germ cell loss. These results are in line with data published in a mouse model of EAO (Pérez 
et al., 2015). In contrast, in isolated Sertoli cells Gal-1 expression was upregulated after 
TNFα stimulation. Addition of exogenous Gal-1 potentiated the TNFα effect in Sertoli cells. 
Therefore, higher Gal-1 levels induced by inflammatory mediators in the inflamed testis 
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could play a pro-inflammatory role in contrast to an anti-inflammatory function as a means to 
sustain immune privilege in the normal testis. In the normal testis Gal-1 produced by Sertoli 
cells is able to promote differentiation of tolerogenic dendritic cells and Treg, further 
supporting a role of endogenous Gal-1 in the maintenance of testicular immune privilege 
(Gao et al., 2016).  
 
5.4. The change of glycocalyx signature in inflamed testis 
 
Gal-1 binds to the disaccharide lactosamine, LacNAc, on complex O-glycans and N-glycans. 
Structural variations of glycans in mammalian cells can strongly affect the binding of 
galectins. As an example Gal-1 can bind to terminal α-2-3 sialic acid capping the 
lactosamine-containing sequence, but not to α-2-6 sialic acid (Stowell et al., 2008). Gal-2 
displayed significantly reduced binding to both α-2-3 sialic acid and α-2-6 sialic acid capping 
the lactosamine-containing sequence (Stowell et al., 2008). In contrast, Gal-3 has a more 
flexible CRD showing that neither α-2-3 sialic acid nor α-2-6 sialic acid decorating the 
lactosamine-containing sequence affects Gal-3 binding (Hirabayashi et al., 2002). Thus, the 
analysis of the glycocalyx signature on the cell surface by specific lectin binding can indicate 
potential binding capacity for different galectins.  
 
The biosynthesis of glycan ligands for binding galectins is regulated by several 
glycosyltransferases (Méndez-Huergo et al., 2017). Expression of Gcnt1 for the synthesis of 
the backbone on O-glycans increases Gal-1 binding to the cell surface (Cedeno-Laurent and 
Dimitroff, 2012). Similarly, activity of Mgat5 associated with the branching of N-glycans can 
also facilitate Gal-1 binding (Thiemann and Baum, 2016). In contrast, expression of St6gal1, 
which is adding a sialic acid to the lactosamine sequences, could abrogate Gal-1 binding 
(Thiemann and Baum, 2016). In Th1 and Th17 cells, overexpression of St6gal1 (adds α-2-6 
sialic acid) could prevent Gal-1 binding and thus the death of cells (Toscano et al., 2007). 
Conversely, masking glycan ends with α-2-6 sialic acid added by the enzyme St6gal1 also 
prevents galectin-9 binding to glycan ligands and induction of T cell death (Bi and Baum, 
2009; Rabinovich and Croci, 2012). 
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As shown by Wang et al. the glycocalyx signature of cells is changed in autoimmune diseases 
like multiple sclerosis and its animal model EAE (Wang et al., 2014). Deficiency of the N-
glycan branching enzyme Mgat5 in mice promotes T cell activity, endocytosis of CTLA-4 
and autoimmunity, including a spontaneous multiple sclerosis (MS)-like disease (Lee et al., 
2007). This study shows that in EAO presence of terminal sialic acid and the sialyltransferase 
St6gal1 was upregulated, while Mgat5 mRNA expression and L-PHA binding were 
decreased. Moreover, SNA binding to primary Sertoli and peritubular cells was increased 
after TNFα stimulation, whereas L-PHA was downregulated. Collectively, these findings 
suggest that under inflammatory conditions the glycan composition on the Sertoli and 
peritubular cell surface becomes less favorable for Gal-1 binding, a means to dampen 
excessive immune reactions elicited otherwise by concerted TNFα and Gal-1 action in sterile 
testicular inflammation. Similar to our findings, Benjamin et al. reported that α-2-6 sialic acid 
was significantly increased on the surface of adipocytes after induction of insulin resistance 
with TNFα (Parker et al., 2016). Likewise, primary human umbilical vein endothelial cells 
showed considerable expression of L-PHA-reactive Mgat5-modified N-glycans, that 
decreased significantly following exposure to pro-inflammatory cytokines like IFNγ and IL-
17, whereas α-2-6 sialic acid expression was increased following IFNγ/IL-17 stimulation 
(Croci et al., 2014). Interestingly, upregulated expression of IFNγ and IL-17 were 
accompanied by increased numbers of Th1 and Th17 cells in EAO testes (Jacobo et al., 2011). 
Thus it could be speculated that the inflammatory cytokines TNFα, IFNγ and IL-17 may be 
involved in the increased expression of α-2-6 sialic acid in EAO testis. 
 
5.5. Gal-1 and TNFα synergistically increased expression of 
inflammatory cytokines through the MAPK p38 and JNK 
 
Galectins as the soluble proteins function in the extracellular milieu by controlling signaling 
pathways through protein–glycan or protein–protein interactions (Cerliani et al., 2017). These 
multivalent complexes (often named lattices) result in high-avidity binding that promote 
cross-linking, reorganization, and clustering of a preferential suit of glycoproteins and 
glycolipids, which could affect signal transduction, endocytosis of receptors, and signaling 
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thresholds of relevant receptors (Rabinovich et al., 2007; Nabi et al., 2015; Cerliani et al., 
2017; Godula, 2018). Likewise, Gal-1 can bind to cellular surface glycoproteins including 
CD3, CD7, CD43 and CD45 and cause an impressive redistribution of these receptors 
modulating signal transduction (Garner and Baum, 2008; Godula, 2018). Lectin-glycan 
interactions can control cell responses by adjusting thresholds of cellular activation.  
 
Gal-1 can induce apoptosis of various cell types including glycosylated thymocytes, activated 
T cells, Leydig cells and breast tumor cells (Martinez et al., 2004; Toscano et al., 2007; 
Geiger et al., 2016). Besides induction of cell death, Gal-1 binding can also prevent cell death, 
mediate epithelial-mesenchymal transition, induce M2 macrophage polarization, regulate 
adhesion and migration, modulate macrophage phagocytosis, promote fibrogenesis, and 
regulate responses to pathogens (Starossom et al., 2012; Bacigalupo et al., 2015; Gaudet et 
al., 2015; Thiemann and Baum, 2016; Bunn et al., 2017; Kathiriya et al., 2017). Gal-1 could 
regulate cell signaling on immature dendritic cells and drive tolerogenic dendritic cells 
through binding to and clustering of CD45 and CD43 (Fulcher et al., 2006, 2009). However, 
on mature, LPS-induced inflammatory dendritic cells, Gal-1 binding to CD43 and clustering 
can prevent cell migration (Thiemann et al., 2015). In order to determine the function of Gal-
1 on one cell type is very important to identify the glycoprotein(s) bound by Gal-1, detect the 
effect of Gal-1 binding on the receptor (such as clustering, internalization, retention on the 
cell surface, enhancing or inhibiting intracellular signal transduction), and determine the final 
outcome of signal transduction.  
 
In this study, we could show that Gal-1 and TNFα synergistically increased the expression of 
inflammatory mediators in Sertoli cells, whereas Gal-1 alone had no effect. This synergistic 
effect is specific because it is abrogated in the presence of lactose and mediated through 
phosphorylation of MAPK p38 and JNK. Additionally, a previous study showed that binding 
of Gal-1 to N-glycan modified CD45 can prolong retention of CD45 on the surface of 
microglial cells by inhibiting early endosome antigen 1 (EAA1) induced endocytosis, and 
thus augment its phosphatase activity (Starossom et al., 2012). Adams et al. showed that 
EEA1 as an endocytosis marker in Sertoli cells is involved in the internalization of 
intercellular junctions (Adams and Wayne Vogl, 2017). It could be speculated that the 
potential mechanisms behind the effect of Gal-1 on TNFα induced inflammatory cytokines in 
                                                                                                                              DISCUSSION 
  - 81 -  
 
Sertoli cells include (a) Gal-1 binding to cellular surface glycoproteins causes substantial 
receptor redistribution and then modulates signal transduction (Figure 26a), and/or (b) 
binding of Gal-1 prolongs retention of receptors and thus augments its activity (Figure 26b). 
For the further study, the glycoprotein(s) bound by Gal-1 on Sertoli cell surface need be also 
identified. 
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Figure 26. Galectin-glycoprotein lattices in the regulation of cell signaling and receptor 
turnover. Gal-1 could bind to cellular surface glycoproteins (receptors) on Sertoli cells and 
cause the redistribution of these receptors, and then modulates signal transduction (a). 
Binding of Gal-1 to cellular surface glycoproteins would prolong retention of receptors on the 
surface of Sertoli cells by inhibiting EAA1 induced endocytosis, and thus augment its activity 
(b). 
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Recent studies have shown that mice lacking Gal-1 developed a reduced incidence and 
severity of symptoms in experimental models of epileptic seizures (Bischoff et al., 2012) and 
EAO (Pérez et al., 2015). In EAO mice deficient for Gal-1 decreased numbers of apoptotic 
germ cells were found compared to testes from normal mice (Pérez et al., 2015). Considering 
that Gal-1 was found to be strongly expressed on apical stalks of Sertoli cells during 
spermiation, involvement in the elimination of defective germ cells is a possible function. 
This hypothesis is supported by studies showing that Gal-1 can induce human T lymphocytes 
and Leydig tumor cell apoptosis by binding to Fas (Biron et al., 2006; Brandt et al., 2008). In 
this regard, upregulation of Fas expression was found in aberrant meiotic and postmeiotic 
germ cells (Francavilla et al., 2002). Because an increased number of Fas positive apoptotic 
germ cells was found in EAO testes (Theas et al., 2003), interaction of Gal-1 and Fas could 
possibly be also involved in germ cell apoptosis in orchitis.  
 
In consideration of our findings that TNFα stimulates Gal-1 expression in Sertoli cells and 
the addition of exogenous Gal-1 enhances the pro-inflammatory effects of TNFα, we propose 
that under normal conditions Gal-1 induces apoptosis of defective germ cells. In contrast, 
under inflammatory conditions Gal-1 adopts a pro-inflammatory and pro-apoptotic function 
in the induction of immune responses and germ cell sloughing. 
 
Taken together, the present data in light of the published literature indicate that under normal 
conditions Gal-1 (mainly produced by Sertoli cells) could be involved in the induction of 
germ cell apoptosis and the maintenance of immune privilege through inducing activated T 
cell apoptosis and promoting the differentiation of tolerogenic dendritic cells (Figure 27a). 
Under inflammatory conditions Gal-1 and TNFα synergistically act to increase expression of 
inflammatory cytokines (e.g. IL-6, MCP-1, TNFα), which may play a role in inflammatory 
reactions and associated testicular damage, characterized by the infiltration of activated T 
cells, M1 macrophage polarization, apoptosis of germ cells and increased terminal α-2-6 
sialylation (Figure 27b). It needs to be considered in this regard that application of 
recombinant Gal-1 to treat autoimmune diseases may elicit an inflammatory response in 
Sertoli cells by the synergistic activity with TNFα. 
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Figure 27. Schematic representation of possible roles of Gal-1 in testis under normal 
and inflammatory conditions. Under normal conditions Gal-1 could induce apoptosis of 
defective germ cells, activation of T cell apoptosis and generation of tolerogenic dendritic 
cells (TDC) in testis and thus maintain the immune privilege (a). In contrast, under 
inflammatory conditions Gal-1 and TNFα induce synergistically expression of inflammatory 
cytokines (e.g. IL-6, MCP-1, TNFα, and IL-1α) via stimulation of MAPK (p38, JNK) 
signaling (b). These cytokines are related to massive immune response (infiltration of 
activated T cells, M1 macrophage polarization), testicular damage, and changes in the 
glycocalyx signature, like increased terminal α-2-6 sialylation (b). (LC: Leydig cells, DC: 
dendritic cells, PTC: peritubular cells, TM: testicular macrophages).  
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Summary  
 
Gal-1 is a multifunctional lectin involved in the modulation of immune responses. Using 
animal models of autoimmunity and chronic inflammation Gal-1 has been shown to have 
anti- as well as pro-inflammatory properties. Here, a model of rat experimental autoimmune 
orchitis (EAO) was used to investigate the role of Gal-1 in chronic testicular inflammation. 
EAO is characterized by leukocytic infiltration in the interstitium, spermatogenic damage and 
elevated production of inflammatory mediators like TNFα and MCP-1. In normal rat testis 
Gal-1 is predominantly expressed in Sertoli and germ cells. In extracts from inflamed testes a 
significant downregulation of Gal-1 mRNA and protein expression was observed. In contrast, 
relative expression of Gal-1 mRNA normalized to SOX9, a Sertoli cell marker, was not 
significantly changed. This suggests that downregulation of Gal-1 in the EAO testis is the 
consequence of germ cell loss.  
 
In order to investigate an influence of Gal-1 on the immune properties of Sertoli cells, 
primary cells were isolated and challenged with the pro-inflammatory cytokine TNFα. 
Subsequently, Gal-1 expression was found to be upregulated. However, binding of the lectin 
SNA to Sertoli cells was increased as shown by flow cytometry. SNA is recognizing terminal 
α-2-6-sialic acid residues that block binding of Gal-1. In contrast, binding of L-PHA, that is 
recognizing β-1-6-branching of complex N-glycans, was downregulated in TNFα challenged 
Sertoli cells. These findings suggest that under inflammatory conditions the glycan 
composition on the Sertoli cell plasma membrane becomes less favorable for Gal-1 binding 
so that excessive immune reactions elicited by concerted action of TNFα and Gal-1 in sterile 
testicular inflammations may be dampened. 
 
Gal-1 and TNFα synergistically increased expression of pro-inflammatory mediators such as 
MCP1, IL-1α, and IL-6 when applied to primary Sertoli cells. These effects were abrogated 
when Gal-1 binding was blocked by preincubation with the galactose containing disaccharide 
lactose. Combined stimulation of Sertoli cells with Gal-1 and TNFα lead to enhanced 
phosphorylation of MAP kinases p38 and JNK as compared to TNFα alone, whereas Gal-1 
alone did not activate MAPK signaling. In addition, treatment of Sertoli cells with p38 and 
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JNK inhibitors abrogated Gal-1 and TNFα induced expression of IL-1 α, TNFα, IL-6 and 
MCP-1 mRNAs. These data show that Gal-1 enhances the pro-inflammatory activity of 
TNFα on Sertoli cells via stimulation of MAPK signaling. 
 
                                                                                                                                  APPENDIX 
  - 87 -  
 
Zusammenfassung 
 
Gal-1 ist ein multifunktionelles Lektin, das an der Modulation von Immunantworten beteiligt 
ist. So konnten in Tiermodellen zu Autoimmunerkrankungen und chronischen Entzündungen 
sowohl anti- als auch pro-inflammatorische Wirkungen von Gal-1 gezeigt werden. In dieser 
Arbeit wurde an einem Modell der experimentellen Autoimmun-Orchitis (EAO) in der Ratte 
die Rolle von Gal-1 bei chronischer testikulärer Entzündung untersucht. Die EAO ist durch 
Leukozyteninfiltrate im Interstitium, Schädigung der Spermatogenese und die Produktion von 
Entzündungsmediatoren wie TNFα und MCP-1 gekennzeichnet. In normalen Rattenhoden 
wurde Gal-1-Expression hauptsächlich in Sertolizellen und Keimzellen gefunden. In 
Extrakten aus entzündeten Hoden war die Expression von Gal-1 auf mRNA- und 
Proteinebene dagegen signifikant erniedrigt. Wurde die Expression von Gal-1 mRNA jedoch 
mit der mRNA Expression von SOX9, einem spezifischen Marker für Sertolizellen, 
normalisiert, dann zeigte sich die Expression im EAO-Hoden unverändert. Die verringerte 
Expression von Gal-1 scheint also auf den Verlust der Keimzellen im entzündeten Hoden 
zurück zu führen zu sein.  
 
Zur Untersuchung des Einflusses von Gal-1 auf die Immuneigenschaften von Sertolizellen 
wurden primäre Sertolizellen aus der Ratte verwendet, die zunächst mit dem 
proinflammatorischen Zytokin TNFα behandelt wurden. Dadurch wurde die Expression von 
Gal-1 sowie die Bindung des Lektins SNA erhöht, SNA erkennt terminale α-2-6-
Sialylsäurereste, die die Bindung von Gal–1 inhibieren. Im Gegensatz dazu war die Bindung 
des Lektins L-PHA, das β-1-6-Verknüpfungen in komplexem N-Glykanen erkennt, an 
stimulierten Sertolizellen erhöht. Unter entzündlichen Bedingungen, wie sie in sterilen 
testikulären Entzündungen durch die gemeinsame Wirkung von TNFα und Gal-1 ausgelöst 
werden können, könnte also die veränderte Zusammensetzung der Glycane auf der 
Oberfläche von Sertolizellen die Bindung von Gal-1 herunter regulieren, um eine 
überschiessende Entzündung zu verhindern.  
 
TNFα konnte die Expression pro-inflammatorischer Mediatoren wie MCP1, IL-1α und IL–6 
in Sertolizellen induzieren, wobei die zusätzliche Inkubation mit Gal-1 die Wirkung von 
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TNFα synergistisch verstärken konnte. In Anwesenheit von Laktose, einem Galaktose 
enthaltenden Disaccharid, konnte dieser Effekt blockiert werden. Im Vergleich zu TNFα 
alleine verstärkte die kombinierte Stimulation von Sertolizellen mit Gal-1 und TNFα die 
Phosphorylierung der MAP-Kinasen p38 und JNK, wogegen Gal-1 alleine MAPK 
Signalwege nicht aktivieren konnte. Darüberhinaus verhinderte die Behandlung von 
Sertolizellen mit p38- und JNK-Inhibitoren, die durch Gal-1 und TNFα induzierte Expression 
von IL-1α, TNFα, IL-6 und MCP-1 mRNA. Diese Daten zeigen also, dass Gal-1 die pro-
inflammatorische Aktivität von TNFα auf Sertolizellen über die Stimulation der MAPK 
Signaltransduktion erhöht. 
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6. APPENDIX 
6.1. Enzymes for Sertoli and peritubular cell isolation  
 
Table 7. List of enzymes used for Sertoli and peritubular cell isolation. 
Enzyme Company Catalogue No. 
Collagenase A Roche Diagnostics, Mannheim, Germany 10103586001 
DNase I Roche Diagnostics, Mannheim, Germany 10104159001 
Hyaluronidase Sigma, Steinheim, Germany H3506 
Trypsin Sigma, Steinheim, Germany T5226 
Trypsin inhibitor Sigma, Steinheim, Germany T6522 
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6.2. Antibodies 
 
Table 8. List of antibodies and antibody dilutions used in this study.  
Primary antibodies Manufacturer Catalogue No. Dilution 
Monoclonal rabbit anti 
galectin-1 
GeneTex, USA GTX62666 1:400*/1:200** 
Polyclonal rabbit anti rat 
vimentin 
Santa Cruz 
Biotechnology, USA 
L4793.AB45 1:200* 
Monoclonal mouse anti rat 
CD68 (ED1) 
AbD Serotec, UK MCA341R 1:200** 
Monoclonal mouse anti rat 
CD163 (ED2) 
AbD Serotec, UK MCA342R 1:200** 
FITC labelled monoclonal 
mouse anti α-smooth muscle 
actin 
Sigma-Aldrich, Germany F3777 1:1000* 
Monoclonal mouse anti-β-actin Sigma-Aldrich, Germany A5441 1:10000* 
Polyclonal rabbit anti rat 
phospho-p38 MAPK 
(Thr180/Tyr182) 
Cell Signaling 
Technology, Germany 
9211 1:1000* 
Polyclonal rabbit anti rat p38 
MAPK 
Cell Signaling 
Technology, Germany 
9212 1:1000* 
Polyclonal rabbit anti rat 
phospho-p44/42 MAPK 
(ERK1/2)  
Cell Signaling 
Technology, Germany 
9101 1:1000* 
Polyclonal rabbit anti rat 
p44/42 MAPK (ERK1/2) 
Cell Signaling 
Technology, Germany 
9102 1:1000* 
Phospho-SAPK/JNK 
(Thr183/Tyr185)  
Cell Signaling 
Technology, Germany 
9251 1:1000* 
SAPK/JNK  Cell Signaling 
Technology, Germany 
9252 1:1000* 
Secondary antibodies Manufacturer Catalogue No. Dilution 
Goat anti rabbit IgG-Alexa 
Fluor 546 
Thermo Fisher Scientific, 
USA 
A11071 1:1000** 
Goat anti mouse IgG-Alexa 
Fluor 448 
Thermo Fisher Scientific, 
USA 
A10684 1:1000** 
Goat anti rabbit IgG-HRP ICN, USA 55676 1:10000* 
Sheep anti mouse IgG-HRP Sigma-Aldrich, Germany A5906 1:10000* 
   IgG: Immunglobulin G, HRP: Horseradish peroxidase, *Western blotting, **Immuno-
fluorescence. 
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6.3. Primers 
 
Table 9. List of primers used in this study. F: forward primer, R: reverse primer. 
Gene Primer (5`→3`) Catalogue No. Gene 
ID 
Amplicon 
size (bp) 
Lgals 1 
(Gal-1) 
PrimePCR SYBR Green Assay qRnoCED0001745 
(Bio-Rad) 
56646 63 
Mgat5 PrimePCR SYBR Green Assay qRnoCID0053085 
(Bio-Rad) 
65271 116 
St6gal1 PrimePCR SYBR Green Assay qRnoCED0004461 
(Bio-Rad) 
25197 63 
Gcnt1 PrimePCR SYBR Green Assay qRnoCED0008631 
(Bio-Rad) 
64043 93 
Hprt F: TCTGTCATGTCGACCCTCAG 
R: CCTTTTCCAAATCTTCAGCA 
/ 24465 109 
Actb         
(β-actin) 
F: ATGGTGGGTATGGGTCAGAA 
R: GGGTCATCTTTTCACGGTTG 
/ 81822 232 
Rn18s (18s 
rRNA) 
F: TACCACATCCAAGGAAGGCAGCA 
R: TGGAATTACCGCGGCTGCTGGCA 
/ 19791 180 
Sox9 F: CTGAAGGGCTACGACTGGAC 
R: TACTGGTCTGCCAGCTTCCT 
/ 140586 140 
Tnf (TNFα) F: GCCTCTTCTCATTCCTGCTC 
R: CCCATTTGGGAACTTCTCCT 
/ 24835 101 
Tgfb2 
(TGFβ2) 
F: CCGGAGGTGATTTCCATCTA 
R: GCGGACGATTCTGAAGTAGG 
/ 81809 201 
Il6 (IL-6) F: GCCCTTCAGGAACAGCTATG 
R: GTCTCCTCTCCGGACTTGTG 
/ 24498 119 
Ccl2    
(MCP-1) 
QuantiTect Primer Assay QT00183253 
(Qiagen) 
24770 117 
Il1a (IL-1α) QuantiTect Primer Assay QT00183670 
(Qiagen) 
24493 101 
 
6.4. List of lectins used in this study. 
 
Table 10. List of conjugated lectins. 
Lectin Origin Binding sites Final concentration 
MAA, FITC conjugated Maackia amurensis Terminal α-2-3-sialylation  20 µg/ml 
PNA, FITC conjugated Arachis hypogaea Core 1 O-glycan 20 µg/ml 
SNA, FITC conjugated Sambucus nigra Terminal α-2-6-sialylation  10 µg/ml 
L-PHA, FITC conjugated Phaseolus vulgaris β-1-6 branching on 
complex N-glycans 
20 µg/ml  
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6.5. Buffers for Sertoli and peritubular cell isolation 
 
Table 11. PBS-A buffer 
Reagents Volume/weight 
PBS Dulbecco’s without Ca2+ and Mg2+ 500 ml 
D-Glucose 750 mg 
100 × Penicillin & Streptomycin 5 ml 
 
Table 12. Trypsin-DNase-solution  
Reagents Volume/weight 
PBS-A 10 ml 
Trypsin 25 mg 
DNase I 100 µg 
 
Table 13. Trypsin inhibitor-solution A  
Reagents Volume/weight 
PBS-A 5 ml 
Trypsin inhibitor 50 mg 
  
Table 14. Trypsin inhibitor-solution B   
Reagents Volume/weight 
PBS-A 10 ml 
Trypsin inhibiter 25 mg 
 
Table 15. Collagenase-hyaluronidase-DNase-solution  
Reagents Volume/weight 
PBS-A 10 ml 
Collagenase A 10 mg 
Hyaluronidase 10 mg 
DNase I 100 µg 
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Table 16. Hyaluronidase-DNase-solution   
Reagents Volume/weight 
PBS-A 10 ml 
Hyaluronidase 10 mg 
DNase I 100 µg 
All enzyme solutions were sterilized by passing through a 0.20 µm filter (Sarstedt, 
Nuembrecht, Germany). 
 
6.6. Culture medium for Sertoli and peritubular cell isolation 
 
Table 17. Sertoli cell culture medium 
Reagents Volume 
RPMI-1640 medium with L-glutamine 495 ml 
100 x Penicillin & Streptomycin 5 ml 
 
Table 18. Peritubular cell culture medium  
Reagents Volume 
RPMI-1640 medium with L-glutamine 445 ml 
Fetal bovine serum 50 ml 
100 x Penicillin & Streptomycin 5 ml 
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6.7. Buffers and solutions for Western blotting 
 
Table 19. RIPA buffer  
Reagents Concentration  
Tris-HCl (pH 8.0) 50 mM 
SDS 0.1% 
Triton X-100 0.1% 
EDTA 2 mM 
Sodium deoxycholate 0.5% 
1 × Proteinase inhibitor cocktail (Sigma-Aldrich, Steinheim, Germany) and 1 × Halt 
Phosphatase Inhibitor Single-Use Cocktail (Thermo Fisher Scientific, Waltham, USA) were 
added fresh just before cell lysis.  
 
Table 20. Laemmli sample loading buffer 
Reagents Concentration  
Tris-HCl (pH 6.8) 50 mM 
SDS 2% 
Glycerol 10% 
β-mercaptoethanol 1% 
EDTA 12.5 mM 
Bromophenol blue 0.02% 
  
Table 21. 10 × Tris buffered saline (pH 7.4) 
Reagents Weight 
Tris base 24.2 g 
NaCl 80 g 
Dissolved in 1 L dH2O. 
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Table 22. Separating gel 
Reagents 10% 12.5% 15% 
dH2O 4.01 ml 3.17 ml 2.35 ml 
1.5 M Tris-HCl pH 8.8 2.5 ml 2.5 ml 2.5 ml 
10% (w/v) SDS 100 µl 100 µl 100 µl 
Acrylamid 3.34 ml 4.17 ml 5 ml 
10% (w/v) APS**
 
50 µl 50 µl 50 µl 
TEMED 5 µl 5 µl 5 µl 
Total 10 ml 10 ml 10 ml 
* Separating gels with different percentages were used according to the molecular weight of 
target proteins (based on 37.5:1 acrylamide/bisacrylamide ratio). 10% gel: 120~40 kDa; 12.5% 
gel: 40~15 kDa; 15% gel: < 20 kDa. 
** 10% APS was prepared fresh before each experiment. 
 
Table 23. Stacking gel 
 
 
 
 
 
 
 
 
 
 
Table 24. Blocking buffer 
Reagents Volume/weight 
1 × TBS 100 ml 
Tween-20 0.1 ml 
Non-fat dry milk 5 g 
  
 
 
 
Reagents 4% 
dH2O 3 ml 
0.5 M Tris-HCl pH 6.8 1.25 ml 
10% (w/v) SDS 50 µl 
Acrylamide 0.65 ml 
10% (w/v) APS**
 
25 µl 
TEMED 5 µl 
Total 5 ml 
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Table 25. 10 × Electrophoresis buffer (pH 8.3) 
Reagents Weight 
Tris base 30.3 g 
Glycine 144 g 
SDS 10 g 
Dissolved in 1 L dH2O. 
 
Table 26. Ponceau S staining solution 
Reagents Concentration  
Ponceau S 2% 
Trichloroacetic acid 30% 
Sulfosalicylic acid 30% 
   
Table 27. Stripping buffer 
Reagents Volume  
1 M Tris-HCl (pH 6.8) 2 ml 
10% SDS 700 µl 
β-mercaptoethanol* 700 µl 
Total 100 ml 
* added freshly just before stripping of membrane. 
 
Table 28. Semi-dry transfer buffer  
Reagents Concentration  
Tris 48 mM 
Glycine 39 mM 
SDS 0.04% 
Methanol 20% (v/v) 
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6.8. Buffer for PCR 
 
Table 29. TAE Buffer 
Reagents Concentration  
Tris-acetate 40 mM 
EDTA, pH 8 1 mM 
  
6.9. Buffer for immunofluorescence staining 
 
Table 30. PBS (10x)   
Reagents Weight 
KCl 2 g 
NaCl 80 g 
Na2PO4 14.4 g 
KH2PO4 2.4 g 
Dissolved in 1 L dH2O, pH adjusted to 7.4 with NaOH. 
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